<!DOCTYPE html>
<!-- saved from url=(0051)https://www.nejm.org/doi/full/10.1056/NEJMoa2412381 -->
<html lang="en" class="pb-page js js-ad-topbanner" data-request-id="93cd748b54380f9f-EWR"><head data-pb-dropzone="head" class="at-element-marker"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style type="text/css" nonce="">.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}</style>
            








    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/1123611~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/build-ffc19f9c2eaa9df9bd7a.css" media="all">
        <link rel="stylesheet" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/print-ffc19f9c2eaa9df9bd7a.css" media="print">
           <link rel="stylesheet" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/build-article-ffc19f9c2eaa9df9bd7a.css" media="all" id="article-style-sheet">
    
        <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/flow.js_7h8bznq6j7bvyvzqcrwvyp8dfb_en-US_20240514181256512029_standard" type="text/javascript"></script><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/capture_login" type="text/javascript"></script><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/mms-prod.js"></script><script nonce="">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/notice" crossorigin="" id="truste_0.28884248984117966"></script>
<script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/core.min.js"></script>
<script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/autoblockoptout"></script>
<!-- /TrustArc Scripts -->
<script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2412381","title":"BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection","category":"Research","type":"Original Article","topics":"Vaccines|Tuberculosis|Infectious Disease General|Global Health","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"First-7-Days-ONL","issueDate":"2025-05-08T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"y"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2412381","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":{"type":"Quick Take","title":"BCG Revaccination to Prevent Mycobacterium tuberculosis Infection","doi":"10.1056/NEJMdo007973","issueDate":"2025-05-08T00:00Z","age":"First-7-Days-ONL","isFree":"n","topics":"Vaccines|Tuberculosis|Infectious Disease General|Global Health","viewType":"Full","specialties":"Infectious Disease"}};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/script.js" nonce=""></script>
<!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async=""></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection"><meta name="dc.Creator" content="Alexander C. Schmidt"><meta name="dc.Creator" content="Lee Fairlie"><meta name="dc.Creator" content="Elizabeth Hellström"><meta name="dc.Creator" content="Angelique Luabeya Kany Kany"><meta name="dc.Creator" content="Keren Middelkoop"><meta name="dc.Creator" content="Kogieleum Naidoo"><meta name="dc.Creator" content="Gonasagrie Nair"><meta name="dc.Creator" content="Anele Gela"><meta name="dc.Creator" content="Elisa Nemes"><meta name="dc.Creator" content="Thomas J. Scriba"><meta name="dc.Creator" content="Amy Cinar"><meta name="dc.Creator" content="Nicole Frahm"><meta name="dc.Creator" content="Robin Mogg"><meta name="dc.Creator" content="David Kaufman"><meta name="dc.Creator" content="Michael W. Dunne"><meta name="dc.Creator" content="Mark Hatherill"><meta name="dc.Description" content="In a previous phase 2 trial, bacille Calmette–Guérin (BCG) revaccination was not shown to provide protection from primary Mycobacterium tuberculosis infection but prevented sustained M. tuberculosi..."><meta name="Description" content="In a previous phase 2 trial, bacille Calmette–Guérin (BCG) revaccination was not shown to provide protection from primary Mycobacterium tuberculosis infection but prevented sustained M. tuberculosi..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2025-05-08"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202505083921806"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="10.1056/NEJMe2502491"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright © 2025 Massachusetts Medical Society. All rights reserved.">





                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection | NEJM">
        <meta property="og:title" content="BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/43bdb9e3-2416-44d5-b50f-c9b68428b98b/nejmoa2412381_f0.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/43bdb9e3-2416-44d5-b50f-c9b68428b98b/nejmoa2412381_f0.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="In a previous phase 2 trial, bacille Calmette–Guérin (BCG) revaccination was not shown
to provide protection from primary Mycobacterium tuberculosis infection but prevented
sustained M. tuberculosi...">
        <meta name="twitter:description" content="In a previous phase 2 trial, bacille Calmette–Guérin (BCG) revaccination was not shown
to provide protection from primary Mycobacterium tuberculosis infection but prevented
sustained M. tuberculosi...">
    


    
    
        <meta property="og:image:width" content="2640">
    


    
    
        <meta property="og:image:height" content="3416">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2412381">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;issue:issue:doi\:10.1056/nejm_2025.392.issue-18;ctype:string:Journal Content;article:article:doi\:10.1056/NEJMoa2412381;wgroup:string:MMS NextGen Website Group;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/AppMeasurement.min.js" async=""></script><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/AppMeasurement_Module_ActivityMap.min.js" async=""></script><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/AppMeasurement_Module_AudienceManagement.min.js" async=""></script><script>
function tgt_setCookie(cname, cvalue, exdays) {
  var d = new Date();
  d.setTime(d.getTime() + (exdays*24*60*60*1000));
  var expires = "expires="+ d.toUTCString();
  document.cookie = cname + "=" + cvalue + ";" + expires + ";path=/";
}
tgt_setCookie("tgt_autodebit", "1");
</script><script id="altmetric-embed-js" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/altmetric_badges-ffa94af28b7f8e4e5169b7ec2ad8e1e94e231143f796594a1ab2753a4fb0acb4.js"></script><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/0-5359f4623045e2978170.js"></script><script charset="utf-8" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/7-ab48cd3588d3cb5ecb1f.js"></script><script charset="utf-8" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/11-04bf2a0da30146b4a5d0.js"></script><style type="text/css" id="bc_async_1746754475081">div[id='bc_home_trend'] {opacity:0.0;filter:alpha(opacity=0);}
</style><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/core.pt5ow5lr.js" type="module"></script><script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/f(1).txt"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link rel="stylesheet" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/providers.css" type="text/css"><meta http-equiv="origin-trial" content="AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="A9wSqI5i0iwGdf6L1CERNdmsTPgVu44ewj8QxTBYgsv1LCPUVF7YmWOvTappqB1139jAymxUW/RO8zmMqo4zlAAAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A+d7vJfYtay4OUbdtRPZA3y7bKQLsxaMEPmxgfhBGqKXNrdkCQeJlUwqa6EBbSfjwFtJWTrWIioXeMW+y8bWAgQAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/f(2).txt" nonce="" async=""></script><link href="https://securepubads.g.doubleclick.net/pagead/managed/dict/m202505080101/gpt" rel="compression-dictionary"><link rel="preconnect" href="https://use.typekit.net/"><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/js" async=""></script><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><meta http-equiv="origin-trial" content="A7CQXglZzTrThjGTBEn1rWTxHOEtkWivwzgea+NjyardrwlieSjVuyG44PkYgIPGs8Q9svD8sF3Yedn0BBBjXAkAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjk1MTY3OTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"><script charset="utf-8" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/8.b8b768ed34bc7505f919.chunk.js"></script></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded mouse-user">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner_Wrap" class="ad-topbanner-outer"><div id="DTM_Position_Topbanner_WrapInner" class="ad-topbanner-inner"><div id="DTM_Position_Topbanner" class="ad ad-topbanner adLabel adLabelVertical" data-google-query-id="COW0usCflY0DFf-kWgUdEVsLlw">
 <!--emptycomment-->
<div id="google_ads_iframe_/21823288697/NEJM/article_1__container__" style="border: 0pt none;"><iframe id="google_ads_iframe_/21823288697/NEJM/article_1" name="google_ads_iframe_/21823288697/NEJM/article_1" title="3rd party ad content" width="728" height="90" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" aria-label="Advertisement" tabindex="0" allow="private-state-token-redemption;attribution-reporting" data-load-complete="true" data-google-container-id="2" style="border: 0px; vertical-align: bottom;" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource(3).html"></iframe></div></div></div></div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="https://www.nejm.org/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="https://www.nejm.org/sign-in?uri=/doi/full/10.1056/NEJMoa2412381" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="https://www.nejm.org/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="https://www.nejm.org/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="https://www.nejm.org/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="https://www.nejm.org/sign-in?uri=/doi/full/10.1056/NEJMoa2412381" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="https://www.nejm.org/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="https://www.nejm.org/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="https://www.nejm.org/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="https://www.nejm.org/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="https://www.nejm.org/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="https://www.nejm.org/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Crisis and Health</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="https://www.nejm.org/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="https://www.nejm.org/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="https://www.nejm.org/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="https://www.nejm.org/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="https://www.nejm.org/sign-in?uri=/doi/full/10.1056/NEJMoa2412381" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="https://www.nejm.org/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="https://www.nejm.org/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="https://www.nejm.org/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="https://www.nejm.org/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2412381" class="inputDoi"><input type="hidden" value="A.C. Schmidt and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2025;392:1789-1800" class="inputCitation"><input type="hidden" value="05-07-2025" class="inputEPubDate"><input type="hidden" value="May 2025" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="BCG Revaccination for the Prevention of &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; Infection" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/build-article-ffc19f9c2eaa9df9bd7a.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="https://www.nejm.org/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/page.js" nonce=""></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="https://www.nejm.org/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="https://www.nejm.org/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="https://www.nejm.org/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="https://www.nejm.org/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="https://www.nejm.org/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> Infection</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Alexander C.</span> <span property="familyName">Schmidt</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lee</span> <span property="familyName">Fairlie</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Elizabeth</span> <span property="familyName">Hellström</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Angelique</span> <span property="familyName">Luabeya Kany Kany</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Keren</span> <span property="familyName">Middelkoop</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Kogieleum</span> <span property="familyName">Naidoo</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gonasagrie</span> <span property="familyName">Nair</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span><span data-displayed-on="all">, <span data-action="reveal" tabindex="0" role="listitem">+9</span> </span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Anele</span> <span property="familyName">Gela</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Elisa</span> <span property="familyName">Nemes</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Thomas J.</span> <span property="familyName">Scriba</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Amy</span> <span property="familyName">Cinar</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Nicole</span> <span property="familyName">Frahm</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Robin</span> <span property="familyName">Mogg</span>, <span property="honorificSuffix">Ph.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">David</span> <span property="familyName">Kaufman</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, <span property="author" typeof="Person" role="listitem"><span property="givenName">Michael W.</span> <span property="familyName">Dunne</span>, <span property="honorificSuffix">M.D.</span></span></span><span data-hidden-on="all">, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Mark</span> <span property="familyName">Hatherill</span>, <span property="honorificSuffix">M.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0003-3491-1809" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-3491-1809</a></span></span>, for <span property="author" typeof="Person" role="listitem">the BCG REVAX Study Team<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fn1" role="doc-noteref">*</a></sup></span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">-9</span></span></span></span><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">May 7, 2025</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2025<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">392</span></span>:<span property="pageStart">1789</span>-<span property="pageEnd">1800</span></div><div class="doi">DOI: 10.1056/NEJMoa2412381</div><div class="core-enumeration"><a href="https://www.nejm.org/toc/nejm/392/18"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">392</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">18</span></span></a></div><div><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#tab-information">Copyright © 2025</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DAlexander%2BC.%2BSchmidt%252C%2BLee%2BFairlie%252C%2BElizabeth%2BHellstr%25C3%25B6m%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D392%26issueNum%3D18%26contentID%3D10.1056%252FNEJMoa2412381%26title%3DBCG%2BRevaccination%2Bfor%2Bthe%2BPrevention%2Bof%2B%253Ci%253EMycobacterium%2Btuberculosis%253C%252Fi%253E%2BInfection%26publicationDate%3D05%252F08%252F2025" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2412381" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="https://www.nejm.org/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DAlexander%2BC.%2BSchmidt%252C%2BLee%2BFairlie%252C%2BElizabeth%2BHellstr%25C3%25B6m%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D392%26issueNum%3D18%26contentID%3D10.1056%252FNEJMoa2412381%26title%3DBCG%2BRevaccination%2Bfor%2Bthe%2BPrevention%2Bof%2B%253Ci%253EMycobacterium%2Btuberculosis%253C%252Fi%253E%2BInfection%26publicationDate%3D05%252F08%252F2025" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#permissions"></use></svg></span></a><a href="https://www.nejm.org/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#reprints"></use></svg></span></a><a href="https://www.nejm.org/author-center/letters-to-the-editor" title="" data-toggle="tooltip" aria-label="Submit a Letter" data-interactiontype="article_tools_submitLetter_click" class="article-tools__submitLetter btn btn--slim" data-original-title="Submit a Letter"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#submitletter01"></use></svg></span></a><a href="https://www.nejm.org/cms/asset/dade39b1-e127-4c31-968b-89af5e572f83/nejmoa2412381.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2412381.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__cme info-panel__item"><a href="https://cme.nejm.org/weekly/10.1056/NEJMcme2412381" class="btn btn--slim btn--cme" aria-label="View CME" data-toggle="tooltip" data-original-title="View CME" data-interactiontype="article_tools_cme_click"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#cme"></use></svg></span></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2412381" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2412381" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2412381.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#summary-abstract" aria-current="true">Abstract</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#sec-1" aria-current="false">Methods</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#sec-2" aria-current="false">Results</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#backnotes" aria-current="false">Notes</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">In a previous phase 2 trial, bacille Calmette–Guérin (BCG) revaccination was not shown to provide protection from primary <i>Mycobacterium tuberculosis</i> infection but prevented sustained <i>M. tuberculosis</i> infection, defined by an initial conversion on a QuantiFERON-TB (QFT) test (an interferon-<i>γ</i> release assay) from negative to positive, followed by two additional positive QFT tests at 3 and 6 months after the initial conversion (a secondary end point). A vaccine efficacy of 45% (95% confidence interval [CI], 6 to 68) was observed.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We performed a phase 2b, double-blind, randomized, placebo-controlled trial to evaluate the efficacy of BCG revaccination, as compared with placebo, for the prevention of sustained QFT test conversion (primary end point) in QFT test–negative, human immunodeficiency virus (HIV)–negative adolescents. Adverse events were assessed in a secondary analysis, and immunogenicity was assessed in an exploratory analysis. Vaccine efficacy was evaluated in the modified intention-to-treat population, which included all the participants who had undergone randomization, received the BCG vaccine or placebo, and had a negative QFT test 10 weeks after receipt of BCG vaccine or placebo; the last criterion was added to exclude participants with <i>M. tuberculosis</i> infection around the time that the vaccine or placebo was administered. Hazard ratios and 95% confidence intervals were estimated from a stratified Cox proportional-hazards model.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><!-- There is no content. --><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f0" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f0.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f0" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f0.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap0">Research Summary</a>.</figcaption></figure></div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">A total of 1836 participants underwent randomization; 918 received the BCG vaccine, and 917 received placebo. After a median 30 months of follow-up, a sustained QFT test conversion was observed in 62 of 871 participants in the BCG-vaccine group and 59 of 849 participants in the placebo group. The hazard ratio for a sustained QFT test conversion (BCG vaccine vs. placebo) was 1.04 (95% CI, 0.73 to 1.48), for a vaccine efficacy point estimate of −3.8% (95% CI, −48.3 to 27.4). <a id="exam-tint-three-a"></a><a id="exam-tint-three-b"></a><span id="tint1" class="named-content" data-type="exam-tint" data-answer-ids="three-a three-b">Adverse events occurred more frequently in the BCG-vaccine group than in the placebo group, and most were due to injection-site reactions (pain, redness, swelling, and ulceration). BCG revaccination induced cytokine-positive type 1 helper CD4 T cells</span>.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph"><a id="exam-tint-two-a"></a><span id="tint2" class="named-content" data-type="exam-tint" data-answer-ids="two-a">BCG revaccination in QFT–test negative, HIV-negative adolescents did not provide protection from sustained <i>M. tuberculosis</i> infection.</span> (Funded by the Gates Foundation; ClinicalTrials.gov number <a href="https://clinicaltrials.gov/study/NCT04152161" target="_blank">NCT04152161</a>.)</div></section></section><div class="core-digital-object quick-take">
<div class="ng-do-media" style="border-top: 1px solid #e5e5e5; padding-top: 1.5rem;">
    <div class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="https://www.nejm.org/do/10.1056/NEJMdo007973/full" class="ng-do-media_item-img-link" data-interactiontype="multimedia_click" data-multimedia-type="Quick Take" data-multimedia-contentid="10.1056/NEJMdo007973">
                <img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmdo007973_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-video"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="https://www.nejm.org/browse/nejm-media-type/quick-take" class="ng-do-media_item-type-link">Quick Take</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="https://www.nejm.org/do/10.1056/NEJMdo007973/full" class="ng-do-media_item-title-link" data-interactiontype="multimedia_click" data-multimedia-type="Quick Take" data-multimedia-contentid="10.1056/NEJMdo007973">BCG Revaccination to Prevent <i>Mycobacterium tuberculosis</i> Infection</a>
            </h6>
            <div class="ng-do-media_item-duration">2m 8s</div>
        </div>
    </div>
</div>
</div></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">Approximately 1.7 billion people are estimated to be infected with <i>Mycobacterium tuberculosis</i> worldwide, of whom approximately 56 million are newly infected and at high risk for progression to tuberculosis disease.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1" href-manipulated="true" aria-label="Reference 1">1</a></sup> In 2022, an estimated 10.6 million new cases of tuberculosis disease were reported worldwide, which included 1.3 million cases in children younger than 15 years of age.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2-1" href-manipulated="true" aria-label="Reference 2">2</a></sup> Tuberculosis disease was responsible for 1.3 million deaths worldwide in 2022, which included 167,000 deaths in persons living with human immunodeficiency virus (HIV) infection.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2-2" href-manipulated="true" aria-label="Reference 2">2</a></sup> The incidence of tuberculosis disease in South Africa is among the highest in the world, with an estimated 468 cases per 100,000 persons in 2022.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2-3" href-manipulated="true" aria-label="Reference 2">2</a></sup> Cohort studies in the Western Cape province showed that the prevalence of <i>M. tuberculosis</i> infection, as assessed by means of an <i>M. tuberculosis</i>–specific interferon-<i>γ</i> release assay (IGRA) such as QuantiFERON-TB (QFT) tests, increases quickly among adolescents,<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r3" role="doc-biblioref" data-xml-rid="r3 r4" id="body-ref-r4" href-manipulated="true">3,4</a></sup> with an incidence of QFT test conversion (from negative to positive) as high as 10% per year.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-2" href-manipulated="true" aria-label="Reference 3">3</a></sup></div><div role="paragraph">A previous phase 2 trial assessed the efficacy of the investigational H4:IC31 vaccine and the bacille Calmette–Guérin (BCG) vaccine, as compared with placebo, for protection against <i>M. tuberculosis</i> infection in healthy QFT test–negative, HIV-negative participants 12 to 17 years of age in South Africa.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-3" href-manipulated="true" aria-label="Reference 3">3</a></sup> BCG revaccination was not shown to provide protection against primary <i>M. tuberculosis</i> infection, defined by an initial QFT test conversion. However, significant vaccine efficacy was observed for the prevention of sustained <i>M. tuberculosis</i> infection, defined by an initial QFT test conversion followed by positive QFT tests at 3 and 6 months thereafter (a secondary end point), with a vaccine efficacy of 45% (95% confidence interval [CI], 6 to 68).<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-4" href-manipulated="true" aria-label="Reference 3">3</a></sup></div><div role="paragraph">One interpretation of the significant result for the prevention of sustained <i>M. tuberculosis</i> infection is that QFT test reversion (from positive to negative) could indicate successful immune control or clearance of <i>M. tuberculosis</i> infection, thus decreasing the risk of progression to disease.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r5" role="doc-biblioref" data-xml-rid="r5" id="body-ref-r5" href-manipulated="true" aria-label="Reference 5">5</a></sup> <a id="exam-tint-one-a"></a><a id="exam-tint-one-b"></a><a id="exam-tint-one-c"></a><a id="exam-tint-one-d"></a><span id="tint3" class="named-content" data-type="exam-tint" data-answer-ids="one-a one-b one-c one-d">However, because progression to tuberculosis disease occurs in no more than 5 to 10% of persons infected with <i>M. tuberculosis</i>, vaccine efficacy for the prevention of sustained <i>M. tuberculosis</i> infection may not predict vaccine efficacy for the prevention of disease if the protective immune response leading to the prevention of sustained infection is induced only in the 90 to 95% of people who would have stayed healthy regardless of vaccination</span>.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6" href-manipulated="true" aria-label="Reference 6">6</a></sup></div><div role="paragraph">In the absence of a licensed vaccine for the prevention of tuberculosis disease in adolescents and adults, we aimed to confirm that BCG revaccination confers protection against sustained <i>M. tuberculosis</i> infection in a larger population with an expanded age range and geographic area and to identify candidate correlates of protection for this trial end point. We assumed that a confirmatory trial could potentially support a policy change for BCG revaccination in South Africa or motivate funders to invest in a large phase 3 trial of BCG revaccination for the prevention of disease in support of the global effort to accelerate the end of the tuberculosis disease epidemic.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r7" role="doc-biblioref" data-xml-rid="r7 r8" id="body-ref-r8" href-manipulated="true">7,8</a></sup> Here we report the results of a phase 2b trial to assess the efficacy of BCG revaccination for the prevention of sustained <i>M. tuberculosis</i> infection in South Africa.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Trial Design and Objectives</h3><div role="paragraph">In this double-blind, phase 2b, randomized, placebo-controlled trial, participants were enrolled at five sites in South Africa: Worcester, Cape Town, and Mbekweni in Western Cape province; Durban in KwaZulu-Natal province; and Johannesburg in Gauteng province. The primary objective was to show the efficacy of BCG revaccination, as compared with placebo, against sustained <i>M. tuberculosis</i> infection in QFT test–negative, healthy adolescents. The QFT Gold-Plus test was used for the assessment of <i>M. tuberculosis</i> infection.</div><div role="paragraph">Secondary objectives were to evaluate the durability of efficacy and the safety and reactogenicity of BCG revaccination. Exploratory objectives were to assess the immunogenicity of BCG revaccination, vaccine efficacy on the basis of alternative definitions of QFT test conversion, and incident cases of laboratory-confirmed tuberculosis disease.</div><div role="paragraph">Participants were randomly assigned in a 1:1 ratio to receive the BCG vaccine (BCG Danish 1331 vaccine, AJ Vaccines) or placebo intradermally (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1">Figure 1</a>). Because the BCG vaccine does not include antigens used in the QFT test, revaccination is not associated with QFT test conversion, and a negative QFT test at day 71 could be used as a criterion for inclusion in the modified intention-to-treat population for the assessment of vaccine efficacy. Randomization was stratified according to age, sex, trial site, and school cluster (Worcester site only). The BCG vaccine was administered according to the instructions provided in the product package insert for South Africa (0.1 ml intradermally). Randomization was performed with the use of a validated interactive voice-response or Web-response system. Trial personnel were unaware of the trial-group assignments until the primary end-point analyses were completed. The expected formation of a papule at the BCG vaccine injection site in most vaccine recipients, starting in the second or third week after vaccination, led to the unblinding of the trial-group assignment for most vaccine recipients and site staff at week 2 or 3. This time frame allowed for an unbiased assessment of solicited adverse events from day 1 through day 7.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f1.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f1.jpg" height="3438" width="2253" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Trial Design and Screening, Randomization, Follow-up, and Analyses.</div><div class="notes"><div role="doc-footnote">Panel A shows the trial design. Participants were randomly assigned to the bacille Calmette–Guérin (BCG)–vaccine group or the placebo group, and QuantiFERON-TB (QFT) tests were performed according to trial schedule. Participants who had a QuantiFERON-TB (QFT) test conversion (negative to positive) at day 71 (or if the visit was missed or not feasible to conduct, at the next feasible visit) were excluded from the primary modified intention-to-treat efficacy analysis but were followed for safety and efficacy to the end of the trial. Each participant was followed for safety for a minimum of 6 months after vaccination. Panel B shows the screening, randomization, follow-up, and analysis. Among 3653 persons who had undergone screening, 1817 were excluded from enrollment. The most common ineligibility criteria were a positive QFT test, altered laboratory values, and an abnormal urinalysis result. Protocol deviations leading to exclusion from the modified intention-to-treat population included nonadherence to the investigational product (3 participants in the BCG-vaccine group) and not meeting all eligibility criteria (1 participant in the BCG-vaccine group and 3 in the placebo group). A total of 1836 underwent randomization in a 1:1 ratio to receive BCG revaccination (919 participants) or placebo (917 participants).</div></div></figcaption></figure></div></section><section id="sec-1-2"><h3>Participants</h3><div role="paragraph">Eligible participants were 10 to 18 years of age and HIV-negative and QFT test–negative at screening. Detailed eligibility criteria are described in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap2">Supplementary Appendix</a> and <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap1">protocol</a>, which are available with the full text of this article at NEJM.org.</div></section><section id="sec-1-3"><h3>End Points and Assessments</h3><div role="paragraph"><a id="exam-tint-two-b"></a><span id="tint4" class="named-content" data-type="exam-tint" data-answer-ids="two-b">The primary end point was a sustained QFT test conversion based on positive QFT tests; an assay threshold of 0.35 IU per milliliter of interferon-<i>γ</i> (established by the manufacturer of the QFT test, Qiagen) was used to determine positivity. Sustained <i>M. tuberculosis</i> infection was defined by a sustained QFT test conversion from negative to positive, with the initial conversion occurring at any time after a first negative QFT test after randomization, followed by positive QFT tests at 3 and 6 months after conversion.</span> The sampling schedule is shown in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1">Figure 1A</a>.</div><div role="paragraph">Secondary end points of the safety and reactogenicity of BCG revaccination were evaluated on the basis of the adverse events reported, as described in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap2">Supplementary Appendix</a>. Exploratory efficacy end points included an initial QFT test conversion, determined on the basis of various interferon-<i>γ</i> thresholds ranging from 0.36 IU per milliliter to 10 IU per milliliter.</div><div role="paragraph">The first 80 participants who were 10 to 12 years of age and had undergone randomization at the Worcester site were enrolled in the immunogenicity subcohort, because this younger age group had not previously been evaluated for immunogenicity. Immunogenicity was assessed in an exploratory analysis with the use of a whole-blood intracellular cytokine staining assay and was determined from the frequency of BCG vaccine–specific CD4 or CD8 T cells expressing one or more of the following cytokines: interferon-<i>γ</i>, tumor necrosis factor, interleukin-2, interleukin-17, and interleukin-22.</div></section><section id="sec-1-4"><h3>Trial Oversight</h3><div role="paragraph">An independent data monitoring committee reviewed unblinded safety data every 3 months during the enrollment period and every 6 months thereafter, as well as the outcomes of the primary analyses. The trial was conducted in accordance with the Good Clinical Practice guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, regulations of the South African Health Products Regulatory Authority, the institutional review board or independent ethics committee at each site, and other applicable country and local requirements. All the authors were involved in the collection and analysis of the data and the review of the manuscript. The first draft of the manuscript was written by the first author, with assistance from a medical writer funded by the Gates Medical Research Institute. The authors vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol.</div></section><section id="sec-1-5"><h3>Statistical Analysis</h3><div role="paragraph">The trial was designed to provide 90% power at a one-sided alpha level of 0.025 for the primary end-point analysis. We assumed that for a true vaccine efficacy of 45%, at least 118 sustained QFT test conversions would be needed to show vaccine efficacy with a lower 95% confidence interval boundary of zero. Vaccine efficacy was calculated as 1 minus the hazard ratio for a sustained QFT test conversion (BCG vaccine vs. placebo).</div><div role="paragraph">The modified intention-to-treat population included all the participants who had undergone randomization, received the BCG vaccine or placebo, and were QFT test–negative at the day 71 visit or at the first trial visit after day 71 for which a QFT test result was available. The safety population included all the participants who had undergone randomization and received the BCG vaccine or placebo. Results are reported as numbers and percentages for categorical variables and as means with standard deviation or medians with minimum–maximum ranges for continuous variables.</div><div role="paragraph">The primary efficacy end point was analyzed with the use of a log-rank test, stratified according to sex and age group (10 or 11 years, 12 to 14 years, and &gt;14 years) to evaluate differences in distributions of event times between the BCG-vaccine group and placebo group. Hazard ratios and 95% confidence intervals were estimated from a stratified Cox proportional-hazards model. Adverse events in different categories were summarized according to trial group, and the 95% confidence intervals were calculated for each proportion of participants with the use of the conditional binomial Clopper–Pearson method with mid-P correction. Adverse events were coded according to the <i>Medical Dictionary for Regulatory Activities</i>, version 26.0 or higher. Adverse events were graded according to the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, version 2.1.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9" href-manipulated="true" aria-label="Reference 9">9</a></sup></div><div role="paragraph">The percentage of missing data was low, with an incidence of early discontinuation of 5.1% in the BCG-vaccine group and 3.9% in the placebo group, which included 1.0% and 0.2% of participants, respectively, who were lost to follow-up and 2.5% of participants in each group who withdrew from the trial. Given that the missingness was minimal and did not appear to be dependent on known factors, we assumed that the data were missing completely at random, and therefore only the observed data were used in analyses.</div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Baseline Characteristics</h3><div role="paragraph">From October 16, 2019, to July 22, 2021, a total of 3653 participants underwent screening, and 1836 were enrolled and underwent randomization (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1">Figure 1B</a>). The representativeness of the trial participants is shown in Table S1 in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap2">Supplementary Appendix</a>. At the time of the primary analysis (data cutoff date, June 30, 2023), a total of 1752 participants had remained in the trial, and 83 (4.5%) had discontinued the trial early. Among the 3653 participants who had undergone screening, 307 had no blood drawn, 12 had indeterminate QFT test results, and 1 had invalid results, and of the remaining 3333 participants with screening QFT test results available, 1219 (36.6%) were QFT test–positive (Table S2). The percentage of participants with positive QFT tests at screening was higher at sites in the Western Cape (37.8 to 39.6%) than in KwaZulu-Natal (29.1%) or Gauteng (23.6%) provinces. Demographic and clinical characteristics of the participants at baseline were similar in the two groups (Table S3). The median age of the participants was 13 years (range, 10 to 18), and most participants (1464 [79.8%]) identified as Black African.</div></section><section id="sec-2-2"><h3>Efficacy</h3><div role="paragraph">The modified intention-to-treat population included 871 participants in the BCG-vaccine group and 849 participants in the placebo group (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1">Figure 1B</a>). Among these participants, 38 (4.1%) in the BCG-vaccine group and 58 (6.3%) in the placebo group were excluded from the modified intention-to-treat population because they had a positive QFT test at day 71; 9 (1.0%) and 8 (0.9%) participants, respectively, were excluded because test results at day 71 were missing and no negative QFT test was documented at the first visit after day 71; and 2 participants (0.2%) in the placebo group were excluded because of indeterminate results at day 71. <a id="exam-tint-two-c"></a><a id="exam-tint-two-d"></a><span id="tint5" class="named-content" data-type="exam-tint" data-answer-ids="two-c two-d">In the primary analysis, which was performed after a median of 30 months (interquartile range, 25 to 33) of follow-up, a sustained QFT test conversion was observed in 62 participants (7.1%; 95% CI, 5.4 to 8.8) in the BCG-vaccine group and 59 participants (7.0%; 95% CI, 5.2 to 8.7) in the placebo group (one-sided P=0.58) (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1">Table 1</a> and <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2">Figure 2A and 2B</a>). The hazard ratio for a sustained test conversion (BCG vaccine vs. placebo) was 1.04 (95% CI, 0.73 to 1.48), for a vaccine efficacy point estimate of −3.8% (95% CI, −48.3 to 27.4). Both the percentage of participants with a sustained QFT test conversion and the cumulative incidence of a sustained QFT test conversion over time were similar in the trial groups.</span> (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1">Table 1</a>). Site-specific point estimates of vaccine efficacy are listed in Table S4.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f2.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f2.jpg" height="1901" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy in the Modified Intention-to-Treat Population.</div><div class="notes"><div role="doc-footnote">Panel A shows the cumulative event curves for a sustained QFT test conversion (primary efficacy end point) according to trial visit. Panel B shows the cumulative event curves for a sustained QFT test conversion according to calendar month. Panel C shows the cumulative event curves for an initial QFT test conversion according to trial visit. Panel D shows the proportion of participants with an initial QFT test conversion based on a range of increasingly stringent QFT test conversion thresholds higher than 0.35 IU per milliliter. 𝙸 bars represent 95% confidence intervals.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_t1.jpg" height="2057" width="1711" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Variable</th><th class="txxx-borders">BCG Vaccine<br>(N=871)</th><th class="txxr-borders">Placebo<br>(N=849)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Initial QFT test conversion on or after day 71 — no. (%)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">135 (15.5)</td><td class="xxxr-borders shading">125 (14.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Not evaluable for QFT test reversion because of missing or indeterminate QFT results — no.</td><td class="xxxx-borders">24</td><td class="xxxr-borders">24</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">QFT test reversion at day 84 or 6 mo after conversion — no.</td><td class="xxxx-borders shading">49</td><td class="xxxr-borders shading">42</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Sustained QFT test conversion<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event</td><td class="xxxx-borders shading">62</td><td class="xxxr-borders shading">59</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Proportion (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">0.0712 (0.0541 to 0.0883)</td><td class="xxxr-borders">0.0695 (0.0524 to 0.0866)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Person-time accrued — mo<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders shading">19,719</td><td class="xxxr-borders shading">19,383</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Overall incidence — no. of events per person-mo (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn6" role="doc-noteref">‖</a></td><td class="xxxx-borders">0.0031 (0.0024 to 0.0040)</td><td class="xxxr-borders">0.0030 (0.0023 to 0.0039)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Hazard ratio (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn7" role="doc-noteref">**</a></td><td class="xxxx-borders shading">1.04 (0.73 to 1.48)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn8" role="doc-noteref">††</a></td><td class="xxxr-borders shading">—</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Vaccine efficacy — % (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn9" role="doc-noteref">‡‡</a></td><td class="xxxx-borders">−3.8 (−48.3 to 27.4)</td><td class="xxxr-borders">—</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Initial QFT test conversion — proportion (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders shading">0.16 (0.13 to 0.18)</td><td class="xxxr-borders shading">0.15 (0.12 to 0.17)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Person-time accrued — mo<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders">19,695</td><td class="xxxr-borders">19,371</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12 shading" data-xml-align="left">Overall incidence — no. of events per person-mo (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn6" role="doc-noteref">‖</a></td><td class="xbxx-borders shading">0.0069 (0.0057 to 0.0081)</td><td class="xbxr-borders shading">0.0065 (0.0054 to 0.0077)</td></tr></tbody></table></div><figcaption><div class="caption">Sustained and Initial QFT Test Conversions.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">All analyses were performed in the modified intention-to-treat population, which included all the participants who had undergone randomization, received the bacille Calmette–Guérin (BCG) vaccine or placebo, and were QuantiFERON-TB (QFT) test–negative at the day 71 visit or at the first trial visit after day 71 for which a QFT test result was available. A QFT test conversion was defined as a change from negative (&lt;0.35 IU per milliliter) on day 71 (or the first visit after a missed day 71 visit) to positive (≥0.35 IU per milliliter). A QFT test reversion was defined as a change from positive to negative. The QFT Gold-Plus test was used for the assessments for <i>M. tuberculosis</i> infection.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t1fn2" role="paragraph">Participants with a first QFT test conversion on or after day 71 (if the day 71 visit was missed) were counted for this end point, irrespective of whether a change from positive to negative occurred on day 84 or at the 6-month visit.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t1fn3" role="paragraph">Participants who had a primary QFT test conversion and continued to have a positive test at both 3 and 6 months after the initial conversion were counted for this end point.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t1fn4" role="paragraph">Proportion was calculated as the number of participants with a QFT test conversion divided by the total number of participants. The 95% confidence intervals were calculated with the use of the Miettinen and Nurminen method without stratification.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16" href-manipulated="true" aria-label="Reference 16">16</a></sup></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="t1fn5" role="paragraph">Person-time was calculated as the time (in months) to conversion if observed or as the censored time if conversion was not observed.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="t1fn6" role="paragraph">Exact confidence intervals were based on a Poisson process with constant intensity.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="t1fn7" role="paragraph">The hazard ratio was calculated with the use of a stratified Cox proportional-hazards model with sex and age group (10 or 11 years, 12 to 14 years, and &gt;14 years) as stratification variables.</div></div><div role="doc-footnote" data-has="label"><div class="label">††</div><div id="t1fn8" role="paragraph">One-sided P=0.58 by log-rank test, stratified according to sex and age group.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡‡</div><div id="t1fn9" role="paragraph">Vaccine efficacy was calculated as 1 minus the hazard ratio (BCG vaccine vs. placebo) for a sustained QFT test conversion. The lower limit of the 95% confidence interval for vaccine efficacy was calculated as 1 minus the upper limit of the 95% confidence interval for the hazard ratio, and the upper limit of the 95% confidence interval for vaccine efficacy as 1 minus the lower limit of the hazard ratio.</div></div></div></figcaption></figure></div><div role="paragraph"><a id="exam-tint-three-d"></a><span id="tint6" class="named-content" data-type="exam-tint" data-answer-ids="three-d">Overall, after day 71, an initial QFT test conversion was observed in 135 participants (15.5%) in the BCG-vaccine group and 125 participants (14.7%) in the placebo group</span> (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1">Table 1</a> and <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2">Figure 2C</a>). The incidence of QFT test reversion was similar in the trial groups (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1">Table 1</a> and Table S5). Among the participants who had an initial QFT test conversion and three consecutive positive or negative QFT tests available, 62 of 111 participants (56%) in the BCG-vaccine group and 59 of 101 participants (58%) in the placebo group had a sustained QFT test conversion, whereas 49 (44%) and 42 (42%), respectively, had a QFT test reversion at day 84 or 6 months after conversion.</div><div role="paragraph">The results for an initial QFT test conversion that were based on a range of increasingly stringent thresholds were similar in the trial groups, regardless of the threshold (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2">Figure 2D</a> and Table S6). For example, an initial QFT test conversion based on a QFT threshold of 4.0 IU per milliliter was observed in 60 participants (6.9%) in the BCG-vaccine group and 64 participants (7.5%) in the placebo group (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2">Figure 2D</a>, Table S6, and Fig. S1). Laboratory-confirmed tuberculosis disease developed in 6 participants in the safety population (3 in the BCG-vaccine group and 3 in the placebo group).</div></section><section id="sec-2-3"><h3>Safety</h3><div role="paragraph">Solicited local adverse events were reported by 77.8% participants in the BCG-vaccine group and 38.1% in the placebo group; 40.5% and 34.3%, respectively, reported having any solicited systemic adverse event (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2">Table 2</a>). Swelling was the most common solicited local adverse event, and tiredness was the most common solicited systemic adverse event.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 2</div><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t2" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t2.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_t2.jpg" height="3438" width="1222" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Adverse Event or Medication Use</th><th class="txxx-borders">BCG Vaccine<br>(N=918)</th><th class="txxr-borders">Placebo<br>(N=917)</th></tr></thead><tbody><tr data-type="row" data-xml-valign="bottom"><td class="xxlx-borders hanging02 shading"><b>Solicited adverse events and medication use</b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Any injection-site symptom</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders shading">754/915</td><td class="xxxr-borders shading">381/915</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">82.4 (79.8 to 84.8)</td><td class="xxxr-borders">41.6 (38.5 to 44.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Any general body symptom</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders">371/916</td><td class="xxxr-borders">314/915</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">40.5 (37.4 to 43.7)</td><td class="xxxr-borders shading">34.3 (31.3 to 37.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Use of medication 1 to 7 days after vaccination</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders shading">30/903</td><td class="xxxr-borders shading">27/899</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">3.3 (2.3 to 4.6)</td><td class="xxxr-borders">3.0 (2.0 to 4.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading"><b>Injection-site symptoms according to severity</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Swelling — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">657/912 (72.0)</td><td class="xxxr-borders shading">248/910 (27.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">2/912 (0.2)</td><td class="xxxr-borders">1/910 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Pain — no./total no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">381/914 (41.7)</td><td class="xxxr-borders">148/915 (16.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">17/914 (1.9)</td><td class="xxxr-borders shading">6/915 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Redness — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">349/912 (38.3)</td><td class="xxxr-borders shading">111/911 (12.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading"><b>Solicited systemic adverse events according to severity</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Tiredness — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">229/913 (25.1)</td><td class="xxxr-borders shading">184/913 (20.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">8/913 (0.9)</td><td class="xxxr-borders">6/913 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Headache — no./total no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">195/913 (21.4)</td><td class="xxxr-borders">164/913 (18.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">7/913 (0.8)</td><td class="xxxr-borders shading">9/913 (1.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Stomach problems — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">136/913 (14.9)</td><td class="xxxr-borders shading">140/913 (15.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">8/913 (0.9)</td><td class="xxxr-borders">8/913 (0.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Fever — no./total no. (%)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">24/911 (2.6)</td><td class="xxxr-borders">27/907 (3.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">5/911 (0.5)</td><td class="xxxr-borders shading">5/907 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02"><b>Adverse-event categories</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Mild adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any mild event — no.</td><td class="xxxx-borders">315</td><td class="xxxr-borders">90</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">34.3 (31.3 to 37.4)</td><td class="xxxr-borders shading">9.8 (8.0 to 11.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Moderate adverse events</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any moderate event — no.</td><td class="xxxx-borders shading">47</td><td class="xxxr-borders shading">28</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">5.1 (3.8 to 6.7)</td><td class="xxxr-borders">3.1 (2.1 to 4.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Severe adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severe event — no.</td><td class="xxxx-borders">5</td><td class="xxxr-borders">3</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.5 (0.2 to 1.2)</td><td class="xxxr-borders shading">0.3 (0.1 to 0.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Related adverse events<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any related event — no.</td><td class="xxxx-borders shading">273</td><td class="xxxr-borders shading">9</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">29.7 (26.8 to 32.8)</td><td class="xxxr-borders">1.0 (0.5 to 1.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Related severe adverse events<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any related severe event — no.</td><td class="xxxx-borders">1</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.1 (0 to 0.5)</td><td class="xxxr-borders shading">—</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Unsolicited nonserious adverse events</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any unsolicited nonserious event — no.</td><td class="xxxx-borders shading">185</td><td class="xxxr-borders shading">117</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">20.2 (17.7 to 22.8)</td><td class="xxxr-borders">12.8 (10.7 to 15.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Serious adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any serious event — no.</td><td class="xxxx-borders">3</td><td class="xxxr-borders">3</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.3 (0.1 to 0.9)</td><td class="xxxr-borders shading">0.3 (0.1 to 0.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Serious adverse event with outcome of death — no.</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Serious adverse drug reaction — no.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn6" role="doc-noteref">‖</a></td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Adverse events leading to premature trial discontinuation — no.</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Adverse events of special interest</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any event of special interest — no.</td><td class="xxxx-borders">5</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.5 (0.2 to 1.2)</td><td class="xxxr-borders shading">—</td></tr><tr data-type="row"><td class="xxlx-borders hanging02"><b>Most common nonserious adverse events</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn7" role="doc-noteref">**</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Headache — no. (%)</td><td class="xxxx-borders shading">36 (3.9)</td><td class="xxxr-borders shading">27 (2.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Injection-site pain — no. (%)</td><td class="xxxx-borders">21 (2.3)</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Injection-site ulceration — no. (%)</td><td class="xxxx-borders shading">20 (2.2)</td><td class="xxxr-borders shading">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Pyrexia — no. (%)</td><td class="xxxx-borders">12 (1.3)</td><td class="xxxr-borders">3 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Oropharyngeal pain — no. (%)</td><td class="xxxx-borders shading">9 (1.0)</td><td class="xxxr-borders shading">4 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02" data-xml-align="left">Upper respiratory tract infection — no. (%)</td><td class="xbxx-borders">8 (0.9)</td><td class="xbxr-borders">15 (1.6)</td></tr></tbody></table></div><figcaption><div class="caption">Incidence of Adverse Events and Medication Use.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t2fn1" role="paragraph">All analyses were performed in the safety population, which included all the participants who had undergone randomization and received the BCG vaccine or placebo. Adverse events were coded according to the <i>Medical Dictionary for Regulatory Activities</i>, version 26.0. Data on solicited adverse events are based on the adverse events reported by the participant on a diary card from days 1 to 7. Data on unsolicited adverse events were collected from the time of screening through day 28. Data on serious adverse events were collected from the time of screening through month 6. Data on serious adverse drug reactions were collected from day 1 through the end of trial. A participant with multiple adverse events within a system organ class or preferred term was counted only once. The 95% confidence intervals were calculated with the use of the conditional binomial Clopper–Pearson method with mid-P correction.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="t2fn2" role="paragraph">Participants were categorized according to the highest severity experienced.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="t2fn3" role="paragraph">Fever was defined as a body temperature of 38.0°C or higher.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="t2fn4" role="paragraph">An adverse event with changing severity was counted only once according to the highest severity.</div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="t2fn5" role="paragraph">Related events were those determined by the site investigator to be related to the assigned regimen.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="t2fn6" role="paragraph">A serious adverse drug reaction was defined as a serious adverse event that was determined by a site investigator to be related to trial regimen.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="t2fn7" role="paragraph">The most common unsolicited adverse events were those that occurred in at least 1% of the participants in any group.</div></div></div></figcaption></figure></div><div role="paragraph">Unsolicited nonserious adverse events occurred in 185 participants (20.2%) in the BCG-vaccine group and 117 participants (12.8%) in the placebo group (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2">Table 2</a>). <a id="exam-tint-three-c"></a><span id="tint7" class="named-content" data-type="exam-tint" data-answer-ids="three-c">The most common unsolicited nonserious adverse events in the BCG-vaccine group were headache (in 3.9%) and injection-site pain (in 2.3%).</span> Most adverse events were mild to moderate in severity. Three participants (0.3%) in each group had serious adverse events, which were determined by the site investigator not to be related to the trial regimen. No serious adverse events leading to death, serious adverse drug reactions, or adverse events leading to premature trial discontinuation were reported. In the BCG-vaccine group, 32 participants had an injection-site scar greater than 10 mm in its largest diameter. Among these participants, 9 had injection-site scars larger than 15 mm, and 2 had scars larger than 20 mm. One large keloid (2.5 cm in its largest diameter) was surgically removed at the participant’s request.</div></section><section id="sec-2-4"><h3>Immunogenicity</h3><div role="paragraph">The frequencies of antigen-specific CD4 T cells expressing any combination of interferon-<i>γ</i>, tumor necrosis factor, interleukin-2, interleukin-17, or interleukin-22 were higher with BCG revaccination than with placebo, which remained higher than baseline 6 months after vaccination (<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3">Figure 3</a> and Figs. S2 and S3). Type 1 helper T-cell responses (CD4 T cells expressing interleukin-2, interferon-<i>γ</i>, or tumor necrosis factor) predominantly accounted for this observation, rather than CD4 T cells expressing interleukin-17 or interleukin-22. A transient increase of CD8 responses to the BCG vaccine was observed at day 29 after vaccination (Fig. S4).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f3.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f3.jpg" height="1494" width="2231" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Immunogenicity of BCG Revaccination.</div><div class="notes"><div role="doc-footnote">Shown are the frequencies of antigen-specific CD4 T cells expressing any combination of interferon-<i>γ</i>, tumor necrosis factor, interleukin-2, interleukin-17, or interleukin-22 after stimulation with BCG vaccine, as measured with the use of whole-blood intracellular cytokine staining assay in participants who received BCG revaccination (orange) or placebo (blue). Panel A shows longitudinal responses (plotted on a logarithmic scale) during the first 168 days after vaccination. 𝙸 bars indicated 95% confidence intervals. Panel B shows the area under the curve (plotted on a logarithmic scale) for BCG-specific CD4 T-cell frequencies per participant during the first 168 days after vaccination. Each circle represents an individual participant. The horizontal line within each box indicates the median, the box indicates the interquartile range (quartile 1 to quartile 3), and the whiskers indicate the minimum and maximum values.</div></div></figcaption></figure></div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">This trial was conducted to assess the findings of an earlier trial involving QFT test–negative, HIV-negative adolescents that showed a significantly lower incidence of sustained QFT test conversion with BCG revaccination than with placebo.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r3" role="doc-biblioref" data-xml-rid="r3" id="body-ref-r3-5" href-manipulated="true" aria-label="Reference 3">3</a></sup> We assumed that confirming the protective effect of BCG revaccination against sustained <i>M. tuberculosis</i> infection, along with providing correlates of protection data, could motivate funders to support a future trial evaluating disease prevention. Although a vaccine efficacy point estimate of 45.4% (95% CI, 6.4 to 68.1) with respect to the prevention of sustained <i>M. tuberculosis</i> infection was observed in the earlier trial, efficacy was not observed in the current trial (vaccine efficacy point estimate, −3.8%; 95% CI, −48.3 to 27.4). The differences in observed efficacy are unlikely due to differences in BCG strain, case definition, biospecimen processing, or assay performance, which were intentionally harmonized. Our trial differed from the previous trial in that it was powered to assess the efficacy of BCG revaccination in the prevention of sustained QFT test conversion (the primary end point) with the use of the QFT Gold-Plus test rather than the QFT Gold In-Tube test. In addition, the number of participants in each trial group in our trial was approximately three times as large as that in the previous trial, and we broadened the age range to include children 10 and 11 years of age, as well as the geographic area to include additional communities in the Western Cape, Gauteng, and KwaZulu-Natal provinces, which have a more diverse population.</div><div role="paragraph">However, geographic or ethnic differences between the trials are unlikely to explain the observed differences in vaccine efficacy, since the observed site-specific vaccine efficacy in this trial at the Worcester site, where 92.7% of the participants in the earlier trial were enrolled, was similar to the overall vaccine efficacy. The overall incidence of initial QFT test conversion in this trial (6.5 to 6.9% per person-year) was lower than the overall incidence reported in the earlier trial (9.9% per person-year). This finding could be due in part to the lockdown related to the coronavirus disease 2019 (Covid-19) pandemic, with extended school closures in 2020 and 2021,<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10-1" href-manipulated="true" aria-label="Reference 10">10</a></sup> and inclusion of trial sites with a lower force of infection (the rate at which susceptible persons acquire an infectious disease). For example, two sites outside the Western Cape province enrolled 20% of participants but contributed only 5.0% [6 of 121] of the participants with a primary end-point event. One observation that differed between this trial and the earlier trial — and which may have contributed to the difference in the observed vaccine efficacy — is that the incidence of QFT test reversion in the placebo group was higher in our trial (42%) than in the earlier trial (25%), whereas the incidence of QFT test reversion in the BCG-vaccine group was similar (44% vs. 46%). Whether the differences in baseline characteristics (with the inclusion of younger children and a more diverse population in the current trial) or the lower intensity of <i>M. tuberculosis</i> exposure (such as that related to Covid-19 lock-down restrictions) contributed to the observed difference in the incidence of reversion remains unknown.</div><div role="paragraph">The safety and reactogenicity data reported here correspond with the known safety profile of the marketed BCG vaccine. This vaccine is well characterized. Larger scars (&gt;10 mm) at the administration site of BCG vaccine were observed in approximately 3% of the BCG vaccine recipients, a finding consistent with previous reports.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11" href-manipulated="true" aria-label="Reference 11">11</a></sup></div><div role="paragraph">A recent trial of BCG revaccination for the prevention of sustained <i>M. tuberculosis</i> infection in 2000 adult health care workers in Brazil showed a lack of vaccine efficacy against either initial or sustained QFT test conversion.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r12" role="doc-biblioref" data-xml-rid="r12" id="body-ref-r12" href-manipulated="true" aria-label="Reference 12">12</a></sup> Given that a lack of vaccine efficacy was observed in two randomized, controlled trials that involved participants with different ancestry and age range and were conducted in locations with a different force of infection, geography, climate, and environmental mycobacteria exposure, the evidence supporting BCG revaccination for the prevention of <i>M. tuberculosis</i> infection appears to have weakened. However, our data do not allow conclusions to be drawn on the potential efficacy of BCG revaccination for the prevention of disease, for which supporting evidence is limited.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r13" role="doc-biblioref" data-xml-rid="r13 r14" id="body-ref-r14-1" href-manipulated="true">13,14</a></sup> A trial evaluating prevention of disease with BCG revaccination trial is currently under way in India and may provide informative data on that end point.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r15" role="doc-biblioref" data-xml-rid="r15" id="body-ref-r15" href-manipulated="true" aria-label="Reference 15">15</a></sup></div><div role="paragraph">Considerable attention has been given to the predictive power of the QFT test for tuberculosis disease, and higher interferon-<i>γ</i> conversion values were previously reported to be associated with a higher risk of progression to tuberculosis disease.<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r13" role="doc-biblioref" data-xml-rid="r13 r14" id="body-ref-r14-2" href-manipulated="true">13,14</a></sup> However, for the prevention of infection, we observed no changes in vaccine efficacy with increasing interferon-<i>γ</i> thresholds, a finding that argues against the possibility that participants with false-positive conversions contributed to the observed lack of vaccine efficacy.</div><div role="paragraph">The strengths of this trial include the use of stringent statistical criteria to assess vaccine efficacy, and the unambiguous results for the primary end point. BCG revaccination did not provide any protection from <i>M. tuberculosis</i> infection as assessed with the use of the QFT test, regardless of whether conversion to infection was defined by a sustained conversion, initial conversion, or conversion with higher interferon-<i>γ</i> thresholds. The trial groups were well balanced in terms of baseline characteristics, and the trial was conducted with stringent monitoring and oversight. The level of participant retention and community engagement was high throughout the trial. A limitation of the trial was that enrollment was paused for 4 months because of restrictions related to the Covid-19 pandemic, and schools were closed for several additional months,<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10-2" href-manipulated="true" aria-label="Reference 10">10</a></sup> which may have contributed to a lower incidence of QFT test conversions.</div><div role="paragraph">Although this trial does not allow us to draw firm conclusions on the efficacy of BCG revaccination for the prevention of disease, the lack of vaccine efficacy with respect to prevention of infection probably decreases the likelihood of BCG revaccination conferring protection against disease.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="data-sharing" role="paragraph">A <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap4">data sharing statement</a> provided by the authors is available with the full text of this article at NEJM.org.</div><div role="paragraph">Supported by the Gates Medical Research Institute through grants from the Gates Foundation (INV-008522 and INV-057216); the Gates Medical Research Institute is a wholly owned subsidiary of the Gates Foundation.</div><div role="paragraph"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap3">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank the trial participants and their families for taking part in this trial; the members of the community advisory board and independent data monitoring committee; the staff at the trial sites and at IQVIA, MMS Holdings, and Bio Analytical Research Corporation South Africa for their contributions; and Madeeha Aqil, Ph.D., for medical writing assistance with an earlier version of the manuscript, which was performed in accordance with Good Publication Practice guidelines.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap0" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Research Summary</span> <span class="core-filename">(nejmoa2412381_research-summary.pdf)</span></div><div class="core-link"><ul><li><a href="https://www.nejm.org/doi/suppl/10.1056/NEJMoa2412381/suppl_file/nejmoa2412381_research-summary.pdf" download="nejmoa2412381_research-summary.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2412381_research-summary.pdf" data-doi="10.1056/NEJMoa2412381">Download</a></li><li>3.39 MB</li></ul></div></div><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Protocol</span> <span class="core-filename">(nejmoa2412381_protocol.pdf)</span></div><div class="core-link"><ul><li><a href="https://www.nejm.org/doi/suppl/10.1056/NEJMoa2412381/suppl_file/nejmoa2412381_protocol.pdf" download="nejmoa2412381_protocol.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2412381_protocol.pdf" data-doi="10.1056/NEJMoa2412381">Download</a></li><li>20.28 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2412381_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="https://www.nejm.org/doi/suppl/10.1056/NEJMoa2412381/suppl_file/nejmoa2412381_appendix.pdf" download="nejmoa2412381_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2412381_appendix.pdf" data-doi="10.1056/NEJMoa2412381">Download</a></li><li>759.55 KB</li></ul></div></div><div id="ap3" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2412381_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="https://www.nejm.org/doi/suppl/10.1056/NEJMoa2412381/suppl_file/nejmoa2412381_disclosures.pdf" download="nejmoa2412381_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2412381_disclosures.pdf" data-doi="10.1056/NEJMoa2412381">Download</a></li><li>1.40 MB</li></ul></div></div><div id="ap4" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Data Sharing Statement</span> <span class="core-filename">(nejmoa2412381_data-sharing.pdf)</span></div><div class="core-link"><ul><li><a href="https://www.nejm.org/doi/suppl/10.1056/NEJMoa2412381/suppl_file/nejmoa2412381_data-sharing.pdf" download="nejmoa2412381_data-sharing.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2412381_data-sharing.pdf" data-doi="10.1056/NEJMoa2412381">Download</a></li><li>71.65 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. <em>PLoS Med</em> 2016;13(10):e1002152-e1002152.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002152" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27780211/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000387656000016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+global+burden+of+latent+tuberculosis+infection%3A+a+re-estimation+using+mathematical+modelling.&amp;publication_year=2016&amp;journal=PLoS+Med&amp;pages=e1002152-e1002152&amp;doi=10.1371%2Fjournal.pmed.1002152&amp;pmid=27780211" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content"><em>Global tuberculosis report 2023</em>. Geneva: World Health Organization, November 17, 2023 (<a href="https://www.who.int/publications/i/item/9789240083851">https://www.who.int/publications/i/item/9789240083851</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Global+tuberculosis+report+2023&amp;publication_year=2023" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] in children younger than 15 years of age. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] immunodeficiency virus (HIV) infection. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 468 cases per 100,000 persons in 2022. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">Nemes E, Geldenhuys H, Rozot V, et al. Prevention of <i>M. tuberculosis</i> ieoplenfection with H4:IC31 vaccine or BCG revaccination. <em>N Engl J Med</em> 2018;379:138-149.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://www.nejm.org/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2412381&amp;key=10.1056%2FNEJMoa1714021&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29996082/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000438249800010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prevention+of+M.+tuberculosis+ieoplenfection+with+H4%3AIC31+vaccine+or+BCG+revaccination.&amp;publication_year=2018&amp;journal=N+Engl+J+Med&amp;pages=138-149&amp;doi=10.1056%2FNEJMoa1714021&amp;pmid=29996082" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] tests, increases quickly among adolescents, </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] to positive) as high as 10% per year. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 12 to 17 years of age in South Africa. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] (95% confidence interval [CI], 6 to 68). </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] with BCG revaccination than with placebo. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. <em>PLoS One</em> 2011;6(3):e17984-e17984.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0017984" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21479236/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000289054600024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+tuberculin+skin+test+versus+QuantiFERON+TB+Gold+in+predicting+tuberculosis+disease+in+an+adolescent+cohort+study+in+South+Africa.&amp;publication_year=2011&amp;journal=PLoS+One&amp;pages=e17984-e17984&amp;doi=10.1371%2Fjournal.pone.0017984&amp;pmid=21479236" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Dale KD, Schwalb A, Coussens AK, et al. Overlooked, dismissed, and downplayed: reversion of <i>Mycobacterium tuberculosis</i> immunoreactivity. <em>Eur Respir Rev</em> 2024;33:240007-240007.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1183/16000617.0007-2024" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/39048129/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001281577300003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Overlooked%2C+dismissed%2C+and+downplayed%3A+reversion+of+Mycobacterium+tuberculosis+immunoreactivity.&amp;publication_year=2024&amp;journal=Eur+Respir+Rev&amp;pages=240007-240007&amp;doi=10.1183%2F16000617.0007-2024&amp;pmid=39048129" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Nemes E, Fiore-Gartland A, Boggiano C, et al. The quest for vaccine-induced immune correlates of protection against tuberculosis. <em>Vaccine Insights</em> 2022;1:165-181.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.18609/vac/2022.027" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/37091190/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+quest+for+vaccine-induced+immune+correlates+of+protection+against+tuberculosis.&amp;publication_year=2022&amp;journal=Vaccine+Insights&amp;pages=165-181&amp;doi=10.18609%2Fvac%2F2022.027&amp;pmid=37091190" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Sumner T, Clark RA, Mukandavire C, et al. Modelling the health and economic impacts ofM72/AS01<sub>E</sub> vaccination and BCG-revaccination: estimates for South Africa. <em>Vaccine</em> 2024;42:1311-1318.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2024.01.072" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/38307747/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001199101300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Modelling+the+health+and+economic+impacts+ofM72%2FAS01E+vaccination+and+BCG-revaccination%3A+estimates+for+South+Africa.&amp;publication_year=2024&amp;journal=Vaccine&amp;pages=1311-1318&amp;doi=10.1016%2Fj.vaccine.2024.01.072&amp;pmid=38307747" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">Clark RA, Sumner T, Weerasuriya CK, Bakker R, Scriba TJ, White RG. Estimating the potential public health value of BCG revaccination. <em>J Infect Dis</em> 2024;230(1):e139-e143.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiae089" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/39052744/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001195910900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimating+the+potential+public+health+value+of+BCG+revaccination.&amp;publication_year=2024&amp;journal=J+Infect+Dis&amp;pages=e139-e143&amp;doi=10.1093%2Finfdis%2Fjiae089&amp;pmid=39052744" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Division of AIDS. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1. Bethesda, MD: National Institute of Allergy and Infectious Diseases, July 2017 (<a href="https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf">https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r9"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Division+of+AIDS+%28DAIDS%29+table+for+grading+the+severity+of+adult+and+pediatric+adverse+events%2C+corrected+version+2.1&amp;publication_year=2017" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">Shepherd D, Mohohlwane N. The impact of COVID-19 in education — more than a year of disruption. Wave 5. Johannesburg: National Income Dynamics (NIDS)-Coronavirus Rapid Mobile Survey (CRAM), July 8, 2021 (<a href="https://cramsurvey.org/wp-content/uploads/2021/07/11.-Shepherd-D-_-Mohohlwane-N.-2021.-Changes-in-education-A-reflection-on-COVID-19-effects-over-a-year.pdf">https://cramsurvey.org/wp-content/uploads/2021/07/11.-Shepherd-D-_-Mohohlwane-N.-2021.-Changes-in-education-A-reflection-on-COVID-19-effects-over-a-year.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+impact+of+COVID-19+in+education+%E2%80%94+more+than+a+year+of+disruption.+Wave+5.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] extended school closures in 2020 and 2021, </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] were closed for several additional months, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Fang JW, Ko BM, Wilson JA. BCG vaccination scars: incidence and acceptance amongst British high-school children. <em>Child Care Health Dev</em> 1993;19:37-43.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1365-2214.1993.tb00711.x" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8425278/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1993KH12600003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+vaccination+scars%3A+incidence+and+acceptance+amongst+British+high-school+children.&amp;publication_year=1993&amp;journal=Child+Care+Health+Dev&amp;pages=37-43&amp;doi=10.1111%2Fj.1365-2214.1993.tb00711.x&amp;pmid=8425278" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Dos Santos PCP, Messina NL, de Oliveira RD, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. <em>Lancet Infect Dis</em> 2024;24:594-601.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r12"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S1473-3099(23)00818-6" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/38423021/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001296588400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effect+of+BCG+vaccination+against+Mycobacterium+tuberculosis+infection+in+adult+Brazilian+health-care+workers%3A+a+nested+clinical+trial.&amp;publication_year=2024&amp;journal=Lancet+Infect+Dis&amp;pages=594-601&amp;doi=10.1016%2FS1473-3099%2823%2900818-6&amp;pmid=38423021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Barreto ML, Pereira SM, Pilger D, et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. <em>Vaccine</em> 2011;29:4875-4877.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2011.05.023" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21616115/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000293043500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Evidence+of+an+effect+of+BCG+revaccination+on+incidence+of+tuberculosis+in+school-aged+children+in+Brazil%3A+second+report+of+the+BCG-REVAC+cluster-randomised+trial.&amp;publication_year=2011&amp;journal=Vaccine&amp;pages=4875-4877&amp;doi=10.1016%2Fj.vaccine.2011.05.023&amp;pmid=21616115" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for which supporting evidence is limited. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of progression to tuberculosis disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">Glynn JR, Fielding K, Mzembe T, et al. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial. <em>Lancet Glob Health</em> 2021;9(10):e1451-e1459.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2214-109X(21)00309-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34534489/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+re-vaccination+in+Malawi%3A+30-year+follow-up+of+a+large%2C+randomised%2C+double-blind%2C+placebo-controlled+trial.&amp;publication_year=2021&amp;journal=Lancet+Glob+Health&amp;pages=e1451-e1459&amp;doi=10.1016%2FS2214-109X%2821%2900309-0&amp;pmid=34534489" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for which supporting evidence is limited. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of progression to tuberculosis disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Prasad R. BCG revaccination study in high-risk adults to begin in 23 states. December 2, 2023. <em>The Hindu</em>. December 3, 2023 (<a href="https://www.thehindu.com/sci-tech/bcg-revaccination-study-in-high-risk-adults-to-begin-in-23-states/article67594580.ece">https://www.thehindu.com/sci-tech/bcg-revaccination-study-in-high-risk-adults-to-begin-in-23-states/article67594580.ece</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+revaccination+study+in+high-risk+adults+to+begin+in+23+states&amp;publication_year=2023" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Miettinen O, Nurminen M. Comparative analysis of two rates. <em>Stat Med</em> 1985;4:213-226.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/sim.4780040211" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4023479/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1985ALC2100010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Comparative+analysis+of+two+rates.&amp;publication_year=1985&amp;journal=Stat+Med&amp;pages=213-226&amp;doi=10.1002%2Fsim.4780040211&amp;pmid=4023479" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="https://www.nejm.org/toc/nejm/392/18"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">392</span></span> • <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">18</span></span> • <span property="datePublished">May 8, 2025</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">1789</span>-<span property="pageEnd">1800</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright © 2025 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: May 7, 2025</div><div><b class="core-label">Published in issue</b>: May 8, 2025</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="https://www.nejm.org/browse/topic/global-health" alt="View article keyword Global Health" data-interactiontype="article_recirculation_click">Global Health</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="https://www.nejm.org/browse/topic/infectious-disease-general" alt="View article keyword Infectious Disease General" data-interactiontype="article_recirculation_click">Infectious Disease General</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="https://www.nejm.org/browse/topic/tuberculosis" alt="View article keyword Tuberculosis" data-interactiontype="article_recirculation_click">Tuberculosis</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="https://www.nejm.org/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Alexander C.</span> <span property="familyName">Schmidt</span>, <span property="honorificSuffix">M.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Lee</span> <span property="familyName">Fairlie</span>, <span property="honorificSuffix">M.B., Ch.B.</span><sup class="xref"><span property="affiliation" typeof="Organization">2</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Elizabeth</span> <span property="familyName">Hellström</span>, <span property="honorificSuffix">M.B., Ch.B.</span><sup class="xref"><span property="affiliation" typeof="Organization">3</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Angelique</span> <span property="familyName">Luabeya Kany Kany</span>, <span property="honorificSuffix">M.B., Ch.B.</span><sup class="xref"><span property="affiliation" typeof="Organization">4</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Keren</span> <span property="familyName">Middelkoop</span>, <span property="honorificSuffix">M.B., Ch.B.</span><sup class="xref"><span property="affiliation" typeof="Organization">5</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Kogieleum</span> <span property="familyName">Naidoo</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">6</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Gonasagrie</span> <span property="familyName">Nair</span>, <span property="honorificSuffix">M.B., Ch.B.</span><sup class="xref"><span property="affiliation" typeof="Organization">5</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Anele</span> <span property="familyName">Gela</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">4</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Elisa</span> <span property="familyName">Nemes</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">4</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Thomas J.</span> <span property="familyName">Scriba</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">4</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Amy</span> <span property="familyName">Cinar</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Nicole</span> <span property="familyName">Frahm</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Robin</span> <span property="familyName">Mogg</span>, <span property="honorificSuffix">Ph.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">David</span> <span property="familyName">Kaufman</span>, <span property="honorificSuffix">M.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, <span property="author" typeof="Person"><span property="givenName">Michael W.</span> <span property="familyName">Dunne</span>, <span property="honorificSuffix">M.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">1</span></sup></span>, and <span property="author" typeof="Person"><span property="givenName">Mark</span> <span property="familyName">Hatherill</span>, <span property="honorificSuffix">M.D.</span><sup class="xref"><span property="affiliation" typeof="Organization">4</span></sup> <a class="orcid-id" href="https://orcid.org/0000-0003-3491-1809" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0003-3491-1809</a></span>, for <span property="author" typeof="Person">the BCG REVAX Study Team<sup><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fn1" role="doc-noteref">*</a></sup></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><sup class="label">1</sup><span property="name">Gates Medical Research Institute, Cambridge, MA</span></div><div property="affiliation" typeof="Organization"><sup class="label">2</sup><span property="name">Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg</span></div><div property="affiliation" typeof="Organization"><sup class="label">3</sup><span property="name">Be Part Yoluntu Centre, Paarl, South Africa</span></div><div property="affiliation" typeof="Organization"><sup class="label">4</sup><span property="name">South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, South Africa</span></div><div property="affiliation" typeof="Organization"><sup class="label">5</sup><span property="name">Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa</span></div><div property="affiliation" typeof="Organization"><sup class="label">6</sup><span property="name">South African Medical Research Council HIV–TB Pathogenesis and Treatment Research Unit, Centre for the AIDS Programme of Research in South Africa, Durban</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Schmidt can be contacted at <a href="mailto:alexander.schmidt@gatesmri.org">alexander.schmidt@gatesmri.org</a> or at the Gates Medical Research Institute, 1 Kendall Sq., Cambridge, MA 02139.</div><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="fn1" role="paragraph">A complete list of members of the BCG REVAX Study Team is provided in the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap2">Supplementary Appendix</a>, available at NEJM.org.</div></div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">1</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2412381" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="4fa7b9d4-b2ea-0b60-9248-5990e298aebd"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=176930537" style="display:inline-block;">
                <img alt="Article has an altmetric score of 61" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=176930537">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_4fa7b9d4-b2ea-0b60-9248-5990e298aebd" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=176930537&amp;tab=news">
          Picked up by <b>1</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=176930537&amp;tab=twitter">
          Posted by <b>47</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #70B1FF;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=176930537&amp;tab=bluesky">
          Referenced by <b>31</b> Bluesky users
      </a>
    </div>


                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/embed.js" nonce=""></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="https://www.nejm.org/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2412381"> <input type="hidden" name="downloadFileName" value="csp_392_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" data-value="endnote" class="dropdown-item">EndNote</a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" data-value="medlars" class="dropdown-item">Medlars</a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="" data-lazyload="false" data-total="1" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Stephen M. Carpenter, </li><li class="list-inline-item cited-by__entry__author">W. Henry Boom, </li></ul><span class="cited-by__entry__title">To BCG or Not Two BCG, </span><span class="cited-by__entry__series-title">New England Journal of Medicine, </span><span class="cited-by__entry__volume"><strong>392</strong>, </span><span class="cited-by__entry__issue">18, </span><span class="cited-by__entry__page-range">(1860-1862), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://www.nejm.org/doi/full/10.1056/NEJMe2502491" title="Abstract" target="_self" class="cited-by__entry__doi">/doi/full/10.1056/NEJMe2502491</a><div class="cited-by__entry__extra-links"><a href="https://www.nejm.org/doi/full/10.1056/NEJMe2502491" target="_self" class="cited-by__entry__visitable">Abstract</a></div></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2412381" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2412381" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2412381.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f0"><figure class="graphic"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f0" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f0.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"></a><figcaption>Download a PDF of the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap0">Research Summary</a>.</figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f0"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f0.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f1.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f1.jpg" height="3438" width="2253" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Trial Design and Screening, Randomization, Follow-up, and Analyses.</div><div class="notes"><div role="doc-footnote">Panel A shows the trial design. Participants were randomly assigned to the bacille Calmette–Guérin (BCG)–vaccine group or the placebo group, and QuantiFERON-TB (QFT) tests were performed according to trial schedule. Participants who had a QuantiFERON-TB (QFT) test conversion (negative to positive) at day 71 (or if the visit was missed or not feasible to conduct, at the next feasible visit) were excluded from the primary modified intention-to-treat efficacy analysis but were followed for safety and efficacy to the end of the trial. Each participant was followed for safety for a minimum of 6 months after vaccination. Panel B shows the screening, randomization, follow-up, and analysis. Among 3653 persons who had undergone screening, 1817 were excluded from enrollment. The most common ineligibility criteria were a positive QFT test, altered laboratory values, and an abnormal urinalysis result. Protocol deviations leading to exclusion from the modified intention-to-treat population included nonadherence to the investigational product (3 participants in the BCG-vaccine group) and not meeting all eligibility criteria (1 participant in the BCG-vaccine group and 3 in the placebo group). A total of 1836 underwent randomization in a 1:1 ratio to receive BCG revaccination (919 participants) or placebo (917 participants).</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f2.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f2.jpg" height="1901" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Vaccine Efficacy in the Modified Intention-to-Treat Population.</div><div class="notes"><div role="doc-footnote">Panel A shows the cumulative event curves for a sustained QFT test conversion (primary efficacy end point) according to trial visit. Panel B shows the cumulative event curves for a sustained QFT test conversion according to calendar month. Panel C shows the cumulative event curves for an initial QFT test conversion according to trial visit. Panel D shows the proportion of participants with an initial QFT test conversion based on a range of increasingly stringent QFT test conversion thresholds higher than 0.35 IU per milliliter. 𝙸 bars represent 95% confidence intervals.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f3.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f3.jpg" height="1494" width="2231" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Immunogenicity of BCG Revaccination.</div><div class="notes"><div role="doc-footnote">Shown are the frequencies of antigen-specific CD4 T cells expressing any combination of interferon-<i>γ</i>, tumor necrosis factor, interleukin-2, interleukin-17, or interleukin-22 after stimulation with BCG vaccine, as measured with the use of whole-blood intracellular cytokine staining assay in participants who received BCG revaccination (orange) or placebo (blue). Panel A shows longitudinal responses (plotted on a logarithmic scale) during the first 168 days after vaccination. 𝙸 bars indicated 95% confidence intervals. Panel B shows the area under the curve (plotted on a logarithmic scale) for BCG-specific CD4 T-cell frequencies per participant during the first 168 days after vaccination. Each circle represents an individual participant. The horizontal line within each box indicates the median, the box indicates the interquartile range (quartile 1 to quartile 3), and the whiskers indicate the minimum and maximum values.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_t1.jpg" height="2057" width="1711" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Variable</th><th class="txxx-borders">BCG Vaccine<br>(N=871)</th><th class="txxr-borders">Placebo<br>(N=849)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Initial QFT test conversion on or after day 71 — no. (%)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">135 (15.5)</td><td class="xxxr-borders shading">125 (14.7)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Not evaluable for QFT test reversion because of missing or indeterminate QFT results — no.</td><td class="xxxx-borders">24</td><td class="xxxr-borders">24</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">QFT test reversion at day 84 or 6 mo after conversion — no.</td><td class="xxxx-borders shading">49</td><td class="xxxr-borders shading">42</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Sustained QFT test conversion<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event</td><td class="xxxx-borders shading">62</td><td class="xxxr-borders shading">59</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Proportion (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">0.0712 (0.0541 to 0.0883)</td><td class="xxxr-borders">0.0695 (0.0524 to 0.0866)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Person-time accrued — mo<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders shading">19,719</td><td class="xxxr-borders shading">19,383</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Overall incidence — no. of events per person-mo (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn6" role="doc-noteref">‖</a></td><td class="xxxx-borders">0.0031 (0.0024 to 0.0040)</td><td class="xxxr-borders">0.0030 (0.0023 to 0.0039)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Hazard ratio (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn7" role="doc-noteref">**</a></td><td class="xxxx-borders shading">1.04 (0.73 to 1.48)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn8" role="doc-noteref">††</a></td><td class="xxxr-borders shading">—</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Vaccine efficacy — % (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn9" role="doc-noteref">‡‡</a></td><td class="xxxx-borders">−3.8 (−48.3 to 27.4)</td><td class="xxxr-borders">—</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Initial QFT test conversion — proportion (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn4" role="doc-noteref">§</a></td><td class="xxxx-borders shading">0.16 (0.13 to 0.18)</td><td class="xxxr-borders shading">0.15 (0.12 to 0.17)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Person-time accrued — mo<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders">19,695</td><td class="xxxr-borders">19,371</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging12 shading" data-xml-align="left">Overall incidence — no. of events per person-mo (95% CI)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn6" role="doc-noteref">‖</a></td><td class="xbxx-borders shading">0.0069 (0.0057 to 0.0081)</td><td class="xbxr-borders shading">0.0065 (0.0054 to 0.0077)</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"></a><div class="notes"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">All analyses were performed in the modified intention-to-treat population, which included all the participants who had undergone randomization, received the bacille Calmette–Guérin (BCG) vaccine or placebo, and were QuantiFERON-TB (QFT) test–negative at the day 71 visit or at the first trial visit after day 71 for which a QFT test result was available. A QFT test conversion was defined as a change from negative (&lt;0.35 IU per milliliter) on day 71 (or the first visit after a missed day 71 visit) to positive (≥0.35 IU per milliliter). A QFT test reversion was defined as a change from positive to negative. The QFT Gold-Plus test was used for the assessments for <i>M. tuberculosis</i> infection.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">Participants with a first QFT test conversion on or after day 71 (if the day 71 visit was missed) were counted for this end point, irrespective of whether a change from positive to negative occurred on day 84 or at the 6-month visit.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">Participants who had a primary QFT test conversion and continued to have a positive test at both 3 and 6 months after the initial conversion were counted for this end point.</div></div></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><div class="label">§</div></a><div id="core-t1fn4" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg">Proportion was calculated as the number of participants with a QFT test conversion divided by the total number of participants. The 95% confidence intervals were calculated with the use of the Miettinen and Nurminen method without stratification.<sup></sup></a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-r16" role="doc-biblioref" data-xml-rid="r16" id="core-body-ref-r16" href-manipulated="true" aria-label="Reference 16" data-to-manipulate="false">16</a></div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="core-t1fn5" role="paragraph" data-to-manipulate="true">Person-time was calculated as the time (in months) to conversion if observed or as the censored time if conversion was not observed.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="core-t1fn6" role="paragraph" data-to-manipulate="true">Exact confidence intervals were based on a Poisson process with constant intensity.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="core-t1fn7" role="paragraph" data-to-manipulate="true">The hazard ratio was calculated with the use of a stratified Cox proportional-hazards model with sex and age group (10 or 11 years, 12 to 14 years, and &gt;14 years) as stratification variables.</div></div><div role="doc-footnote" data-has="label"><div class="label">††</div><div id="core-t1fn8" role="paragraph" data-to-manipulate="true">One-sided P=0.58 by log-rank test, stratified according to sex and age group.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡‡</div><div id="core-t1fn9" role="paragraph" data-to-manipulate="true">Vaccine efficacy was calculated as 1 minus the hazard ratio (BCG vaccine vs. placebo) for a sustained QFT test conversion. The lower limit of the 95% confidence interval for vaccine efficacy was calculated as 1 minus the upper limit of the 95% confidence interval for the hazard ratio, and the upper limit of the 95% confidence interval for vaccine efficacy as 1 minus the lower limit of the hazard ratio.</div></div></div></figcaption><figcaption><div class="caption">Sustained and Initial QFT Test Conversions.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t2"><figure class="table"><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t2.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_t2.jpg" height="3438" width="1222" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Adverse Event or Medication Use</th><th class="txxx-borders">BCG Vaccine<br>(N=918)</th><th class="txxr-borders">Placebo<br>(N=917)</th></tr></thead><tbody><tr data-type="row" data-xml-valign="bottom"><td class="xxlx-borders hanging02 shading"><b>Solicited adverse events and medication use</b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Any injection-site symptom</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders shading">754/915</td><td class="xxxr-borders shading">381/915</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">82.4 (79.8 to 84.8)</td><td class="xxxr-borders">41.6 (38.5 to 44.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Any general body symptom</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders">371/916</td><td class="xxxr-borders">314/915</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">40.5 (37.4 to 43.7)</td><td class="xxxr-borders shading">34.3 (31.3 to 37.4)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Use of medication 1 to 7 days after vaccination</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">No. with event/total no.</td><td class="xxxx-borders shading">30/903</td><td class="xxxr-borders shading">27/899</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">3.3 (2.3 to 4.6)</td><td class="xxxr-borders">3.0 (2.0 to 4.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading"><b>Injection-site symptoms according to severity</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Swelling — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">657/912 (72.0)</td><td class="xxxr-borders shading">248/910 (27.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">2/912 (0.2)</td><td class="xxxr-borders">1/910 (0.1)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Pain — no./total no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">381/914 (41.7)</td><td class="xxxr-borders">148/915 (16.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">17/914 (1.9)</td><td class="xxxr-borders shading">6/915 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Redness — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">349/912 (38.3)</td><td class="xxxr-borders shading">111/911 (12.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading"><b>Solicited systemic adverse events according to severity</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn2" role="doc-noteref">†</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Tiredness — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">229/913 (25.1)</td><td class="xxxr-borders shading">184/913 (20.2)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">8/913 (0.9)</td><td class="xxxr-borders">6/913 (0.7)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Headache — no./total no. (%)</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">195/913 (21.4)</td><td class="xxxr-borders">164/913 (18.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">7/913 (0.8)</td><td class="xxxr-borders shading">9/913 (1.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Stomach problems — no./total no. (%)</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any severity</td><td class="xxxx-borders shading">136/913 (14.9)</td><td class="xxxr-borders shading">140/913 (15.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders">8/913 (0.9)</td><td class="xxxr-borders">8/913 (0.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Fever — no./total no. (%)<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn3" role="doc-noteref">‡</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severity</td><td class="xxxx-borders">24/911 (2.6)</td><td class="xxxr-borders">27/907 (3.0)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Severe or life-threatening</td><td class="xxxx-borders shading">5/911 (0.5)</td><td class="xxxr-borders shading">5/907 (0.6)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02"><b>Adverse-event categories</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn4" role="doc-noteref">§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Mild adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any mild event — no.</td><td class="xxxx-borders">315</td><td class="xxxr-borders">90</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">34.3 (31.3 to 37.4)</td><td class="xxxr-borders shading">9.8 (8.0 to 11.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Moderate adverse events</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any moderate event — no.</td><td class="xxxx-borders shading">47</td><td class="xxxr-borders shading">28</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">5.1 (3.8 to 6.7)</td><td class="xxxr-borders">3.1 (2.1 to 4.3)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Severe adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any severe event — no.</td><td class="xxxx-borders">5</td><td class="xxxr-borders">3</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.5 (0.2 to 1.2)</td><td class="xxxr-borders shading">0.3 (0.1 to 0.9)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Related adverse events<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any related event — no.</td><td class="xxxx-borders shading">273</td><td class="xxxr-borders shading">9</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">29.7 (26.8 to 32.8)</td><td class="xxxr-borders">1.0 (0.5 to 1.8)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Related severe adverse events<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn5" role="doc-noteref">¶</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any related severe event — no.</td><td class="xxxx-borders">1</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.1 (0 to 0.5)</td><td class="xxxr-borders shading">—</td></tr><tr data-type="row"><td class="xxlx-borders hanging02">Unsolicited nonserious adverse events</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Any unsolicited nonserious event — no.</td><td class="xxxx-borders shading">185</td><td class="xxxr-borders shading">117</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders">20.2 (17.7 to 22.8)</td><td class="xxxr-borders">12.8 (10.7 to 15.0)</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Serious adverse events</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any serious event — no.</td><td class="xxxx-borders">3</td><td class="xxxr-borders">3</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.3 (0.1 to 0.9)</td><td class="xxxr-borders shading">0.3 (0.1 to 0.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Serious adverse event with outcome of death — no.</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Serious adverse drug reaction — no.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn6" role="doc-noteref">‖</a></td><td class="xxxx-borders shading">0</td><td class="xxxr-borders shading">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Adverse events leading to premature trial discontinuation — no.</td><td class="xxxx-borders">0</td><td class="xxxr-borders">0</td></tr><tr data-type="row"><td class="xxlx-borders hanging02 shading">Adverse events of special interest</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12" data-xml-align="left">Any event of special interest — no.</td><td class="xxxx-borders">5</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging12 shading" data-xml-align="left">Percent (95% CI)</td><td class="xxxx-borders shading">0.5 (0.2 to 1.2)</td><td class="xxxr-borders shading">—</td></tr><tr data-type="row"><td class="xxlx-borders hanging02"><b>Most common nonserious adverse events</b><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn7" role="doc-noteref">**</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Headache — no. (%)</td><td class="xxxx-borders shading">36 (3.9)</td><td class="xxxr-borders shading">27 (2.9)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Injection-site pain — no. (%)</td><td class="xxxx-borders">21 (2.3)</td><td class="xxxr-borders">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Injection-site ulceration — no. (%)</td><td class="xxxx-borders shading">20 (2.2)</td><td class="xxxr-borders shading">0</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02" data-xml-align="left">Pyrexia — no. (%)</td><td class="xxxx-borders">12 (1.3)</td><td class="xxxr-borders">3 (0.3)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging02 shading" data-xml-align="left">Oropharyngeal pain — no. (%)</td><td class="xxxx-borders shading">9 (1.0)</td><td class="xxxr-borders shading">4 (0.4)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging02" data-xml-align="left">Upper respiratory tract infection — no. (%)</td><td class="xbxx-borders">8 (0.9)</td><td class="xbxr-borders">15 (1.6)</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t2fn1" role="paragraph" data-to-manipulate="true">All analyses were performed in the safety population, which included all the participants who had undergone randomization and received the BCG vaccine or placebo. Adverse events were coded according to the <i>Medical Dictionary for Regulatory Activities</i>, version 26.0. Data on solicited adverse events are based on the adverse events reported by the participant on a diary card from days 1 to 7. Data on unsolicited adverse events were collected from the time of screening through day 28. Data on serious adverse events were collected from the time of screening through month 6. Data on serious adverse drug reactions were collected from day 1 through the end of trial. A participant with multiple adverse events within a system organ class or preferred term was counted only once. The 95% confidence intervals were calculated with the use of the conditional binomial Clopper–Pearson method with mid-P correction.</div></div><div role="doc-footnote" data-has="label"><div class="label">†</div><div id="core-t2fn2" role="paragraph" data-to-manipulate="true">Participants were categorized according to the highest severity experienced.</div></div><div role="doc-footnote" data-has="label"><div class="label">‡</div><div id="core-t2fn3" role="paragraph" data-to-manipulate="true">Fever was defined as a body temperature of 38.0°C or higher.</div></div><div role="doc-footnote" data-has="label"><div class="label">§</div><div id="core-t2fn4" role="paragraph" data-to-manipulate="true">An adverse event with changing severity was counted only once according to the highest severity.</div></div><div role="doc-footnote" data-has="label"><div class="label">¶</div><div id="core-t2fn5" role="paragraph" data-to-manipulate="true">Related events were those determined by the site investigator to be related to the assigned regimen.</div></div><div role="doc-footnote" data-has="label"><div class="label">‖</div><div id="core-t2fn6" role="paragraph" data-to-manipulate="true">A serious adverse drug reaction was defined as a serious adverse event that was determined by a site investigator to be related to trial regimen.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="core-t2fn7" role="paragraph" data-to-manipulate="true">The most common unsolicited adverse events were those that occurred in at least 1% of the participants in any group.</div></div></div></figcaption></a><figcaption><div class="caption">Incidence of Adverse Events and Medication Use.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#core-t2fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2412381_t2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2412381</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="https://www.nejm.org/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="https://www.nejm.org/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="https://www.nejm.org/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="https://www.nejm.org/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="https://www.nejm.org/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. <em>PLoS Med</em> 2016;13(10):e1002152-e1002152.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pmed.1002152" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27780211/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000387656000016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+global+burden+of+latent+tuberculosis+infection%3A+a+re-estimation+using+mathematical+modelling.&amp;publication_year=2016&amp;journal=PLoS+Med&amp;pages=e1002152-e1002152&amp;doi=10.1371%2Fjournal.pmed.1002152&amp;pmid=27780211" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content"><em>Global tuberculosis report 2023</em>. Geneva: World Health Organization, November 17, 2023 (<a href="https://www.who.int/publications/i/item/9789240083851">https://www.who.int/publications/i/item/9789240083851</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r2-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Global+tuberculosis+report+2023&amp;publication_year=2023" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r2-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] in children younger than 15 years of age. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] immunodeficiency virus (HIV) infection. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r2-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 468 cases per 100,000 persons in 2022. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">Nemes E, Geldenhuys H, Rozot V, et al. Prevention of <i>M. tuberculosis</i> ieoplenfection with H4:IC31 vaccine or BCG revaccination. <em>N Engl J Med</em> 2018;379:138-149.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r3-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://www.nejm.org/servlet/linkout?suffix=e_1_3_5_4_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2412381&amp;key=10.1056%2FNEJMoa1714021&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29996082/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000438249800010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Prevention+of+M.+tuberculosis+ieoplenfection+with+H4%3AIC31+vaccine+or+BCG+revaccination.&amp;publication_year=2018&amp;journal=N+Engl+J+Med&amp;pages=138-149&amp;doi=10.1056%2FNEJMoa1714021&amp;pmid=29996082" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r3-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] tests, increases quickly among adolescents, </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] to positive) as high as 10% per year. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] 12 to 17 years of age in South Africa. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] (95% confidence interval [CI], 6 to 68). </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r3-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] with BCG revaccination than with placebo. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. <em>PLoS One</em> 2011;6(3):e17984-e17984.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r4"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0017984" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21479236/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000289054600024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+tuberculin+skin+test+versus+QuantiFERON+TB+Gold+in+predicting+tuberculosis+disease+in+an+adolescent+cohort+study+in+South+Africa.&amp;publication_year=2011&amp;journal=PLoS+One&amp;pages=e17984-e17984&amp;doi=10.1371%2Fjournal.pone.0017984&amp;pmid=21479236" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Dale KD, Schwalb A, Coussens AK, et al. Overlooked, dismissed, and downplayed: reversion of <i>Mycobacterium tuberculosis</i> immunoreactivity. <em>Eur Respir Rev</em> 2024;33:240007-240007.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1183/16000617.0007-2024" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/39048129/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001281577300003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Overlooked%2C+dismissed%2C+and+downplayed%3A+reversion+of+Mycobacterium+tuberculosis+immunoreactivity.&amp;publication_year=2024&amp;journal=Eur+Respir+Rev&amp;pages=240007-240007&amp;doi=10.1183%2F16000617.0007-2024&amp;pmid=39048129" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Nemes E, Fiore-Gartland A, Boggiano C, et al. The quest for vaccine-induced immune correlates of protection against tuberculosis. <em>Vaccine Insights</em> 2022;1:165-181.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.18609/vac/2022.027" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/37091190/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+quest+for+vaccine-induced+immune+correlates+of+protection+against+tuberculosis.&amp;publication_year=2022&amp;journal=Vaccine+Insights&amp;pages=165-181&amp;doi=10.18609%2Fvac%2F2022.027&amp;pmid=37091190" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Sumner T, Clark RA, Mukandavire C, et al. Modelling the health and economic impacts ofM72/AS01<sub>E</sub> vaccination and BCG-revaccination: estimates for South Africa. <em>Vaccine</em> 2024;42:1311-1318.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2024.01.072" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/38307747/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001199101300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Modelling+the+health+and+economic+impacts+ofM72%2FAS01E+vaccination+and+BCG-revaccination%3A+estimates+for+South+Africa.&amp;publication_year=2024&amp;journal=Vaccine&amp;pages=1311-1318&amp;doi=10.1016%2Fj.vaccine.2024.01.072&amp;pmid=38307747" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">Clark RA, Sumner T, Weerasuriya CK, Bakker R, Scriba TJ, White RG. Estimating the potential public health value of BCG revaccination. <em>J Infect Dis</em> 2024;230(1):e139-e143.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/infdis/jiae089" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/39052744/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001195910900001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimating+the+potential+public+health+value+of+BCG+revaccination.&amp;publication_year=2024&amp;journal=J+Infect+Dis&amp;pages=e139-e143&amp;doi=10.1093%2Finfdis%2Fjiae089&amp;pmid=39052744" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Division of AIDS. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1. Bethesda, MD: National Institute of Allergy and Infectious Diseases, July 2017 (<a href="https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf">https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r9"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Division+of+AIDS+%28DAIDS%29+table+for+grading+the+severity+of+adult+and+pediatric+adverse+events%2C+corrected+version+2.1&amp;publication_year=2017" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">Shepherd D, Mohohlwane N. The impact of COVID-19 in education — more than a year of disruption. Wave 5. Johannesburg: National Income Dynamics (NIDS)-Coronavirus Rapid Mobile Survey (CRAM), July 8, 2021 (<a href="https://cramsurvey.org/wp-content/uploads/2021/07/11.-Shepherd-D-_-Mohohlwane-N.-2021.-Changes-in-education-A-reflection-on-COVID-19-effects-over-a-year.pdf">https://cramsurvey.org/wp-content/uploads/2021/07/11.-Shepherd-D-_-Mohohlwane-N.-2021.-Changes-in-education-A-reflection-on-COVID-19-effects-over-a-year.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r10-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+impact+of+COVID-19+in+education+%E2%80%94+more+than+a+year+of+disruption.+Wave+5.&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r10-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r10-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] extended school closures in 2020 and 2021, </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r10-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] were closed for several additional months, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Fang JW, Ko BM, Wilson JA. BCG vaccination scars: incidence and acceptance amongst British high-school children. <em>Child Care Health Dev</em> 1993;19:37-43.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r11"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1365-2214.1993.tb00711.x" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8425278/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1993KH12600003" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+vaccination+scars%3A+incidence+and+acceptance+amongst+British+high-school+children.&amp;publication_year=1993&amp;journal=Child+Care+Health+Dev&amp;pages=37-43&amp;doi=10.1111%2Fj.1365-2214.1993.tb00711.x&amp;pmid=8425278" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Dos Santos PCP, Messina NL, de Oliveira RD, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. <em>Lancet Infect Dis</em> 2024;24:594-601.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r12"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S1473-3099(23)00818-6" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/38423021/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=001296588400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effect+of+BCG+vaccination+against+Mycobacterium+tuberculosis+infection+in+adult+Brazilian+health-care+workers%3A+a+nested+clinical+trial.&amp;publication_year=2024&amp;journal=Lancet+Infect+Dis&amp;pages=594-601&amp;doi=10.1016%2FS1473-3099%2823%2900818-6&amp;pmid=38423021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Barreto ML, Pereira SM, Pilger D, et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial. <em>Vaccine</em> 2011;29:4875-4877.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r13-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.vaccine.2011.05.023" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21616115/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000293043500001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Evidence+of+an+effect+of+BCG+revaccination+on+incidence+of+tuberculosis+in+school-aged+children+in+Brazil%3A+second+report+of+the+BCG-REVAC+cluster-randomised+trial.&amp;publication_year=2011&amp;journal=Vaccine&amp;pages=4875-4877&amp;doi=10.1016%2Fj.vaccine.2011.05.023&amp;pmid=21616115" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r13-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for which supporting evidence is limited. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of progression to tuberculosis disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">Glynn JR, Fielding K, Mzembe T, et al. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial. <em>Lancet Glob Health</em> 2021;9(10):e1451-e1459.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r14-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2214-109X(21)00309-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34534489/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+re-vaccination+in+Malawi%3A+30-year+follow-up+of+a+large%2C+randomised%2C+double-blind%2C+placebo-controlled+trial.&amp;publication_year=2021&amp;journal=Lancet+Glob+Health&amp;pages=e1451-e1459&amp;doi=10.1016%2FS2214-109X%2821%2900309-0&amp;pmid=34534489" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r14-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] for which supporting evidence is limited. </span></a></li><li role="none"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r14-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] of progression to tuberculosis disease. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Prasad R. BCG revaccination study in high-risk adults to begin in 23 states. December 2, 2023. <em>The Hindu</em>. December 3, 2023 (<a href="https://www.thehindu.com/sci-tech/bcg-revaccination-study-in-high-risk-adults-to-begin-in-23-states/article67594580.ece">https://www.thehindu.com/sci-tech/bcg-revaccination-study-in-high-risk-adults-to-begin-in-23-states/article67594580.ece</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=BCG+revaccination+study+in+high-risk+adults+to+begin+in+23+states&amp;publication_year=2023" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Miettinen O, Nurminen M. Comparative analysis of two rates. <em>Stat Med</em> 1985;4:213-226.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#body-ref-r16"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/sim.4780040211" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4023479/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=A1985ALC2100010" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Comparative+analysis+of+two+rates.&amp;publication_year=1985&amp;journal=Stat+Med&amp;pages=213-226&amp;doi=10.1002%2Fsim.4780040211&amp;pmid=4023479" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad adLabel" data-google-query-id="COa0usCflY0DFf-kWgUdEVsLlw">
 <!--emptycomment-->
<div id="google_ads_iframe_/21823288697/NEJM/article_2__container__" style="border: 0pt none;"><iframe id="google_ads_iframe_/21823288697/NEJM/article_2" name="google_ads_iframe_/21823288697/NEJM/article_2" title="3rd party ad content" width="300" height="250" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" aria-label="Advertisement" tabindex="0" allow="private-state-token-redemption;attribution-reporting" data-load-complete="true" data-google-container-id="3" style="border: 0px; vertical-align: bottom;" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource(4).html"></iframe></div></div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        <div class="ng-related-articles"><h3 class="ng-subsection-title"><span class="ng-subsection-title_text">Related articles</span></h3><ul class="ng-related-articles_list"><li class="ng-related-articles_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="https://www.nejm.org/browse/nejm-article-type/editorial" class="issue-item_type">Editorial</a></li><li class="issue-item_meta-item"><span class="issue-item_date">May 07, 2025</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMe2502491" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">To BCG or Not Two BCG</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">S.M. Carpenter and W.H. Boom</span></div></div></div></div></div></li></ul></div>

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">May 8, 2025</div><div class="nejm-widget_item"><div><span> Ronan, Montana</span></div><div><span>Cardiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/880181/non-invasive-cardiology-in-western-montana/?query=fjwp&amp;rid=338868">Non-Invasive Cardiology in Western Montana</a></div></div><div class="nejm-widget_item"><div><span> Wheat Ridge, Colorado</span></div><div><span>Cardiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/867360/heart-failure-cardiologist/?query=fjwp&amp;rid=751">Heart Failure Cardiologist</a></div></div><div class="nejm-widget_item"><div><span> Bellingham, Washington State</span></div><div><span>Gastroenterology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/869242/gastroenterologist-per-diem/?query=fjwf&amp;rid=14710">Gastroenterologist - per diem</a></div></div><div class="nejm-widget_item"><div><span> Salem, Massachusetts</span></div><div><span>Cardiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/870728/non-invasive-cardiologist-salem-ma/?query=fjwp&amp;rid=428606">Non-Invasive Cardiologist - Salem, MA</a></div></div><div class="nejm-widget_item"><div><span> Charlottesville, Virginia</span></div><div><span>Cardiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/782219/uva-faculty-structural-echocardiographer-charlottesville-virginia/?query=fjwf&amp;rid=468039">UVA Faculty | Structural Echocardiographer Charlottesville, Virginia</a></div></div><div class="nejm-widget_item"><div><span> Lebanon, New Hampshire</span></div><div><span>Gastroenterology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/875699/advanced-staff-endoscopy-fellow-2025/?query=fjwf&amp;rid=217510">Advanced Staff Endoscopy Fellow 2025</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource(1)"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1" class="mbox-name-N-ad-article-right-rail-300x250-1 at-element-marker" data-mbox="N-ad-article-right-rail-300x250-1" style="opacity: 1;">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="https://www.nejm.org/action/clickThrough?id=128129&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejm%2Fregister%2Falerts%3Fpromo%3DONFQSR51%26query%3Dcm_rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Dalerts23&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2412381&amp;pubId=41391865&amp;placeholderId=101337&amp;productId=1035"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/rightRail--SpecialtyUpdates23-001.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/webcomponents-loader.js" async="" nonce="">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="93cd748b54380f9f-EWR"></script>
<script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/more-like-this.js" type="module" nonce=""></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$396404622$--><onepub-fonts><template shadowrootmode="open"><!----><slot></slot></template><wc-fetch><template shadowrootmode="open"><!----><slot><!--?lit$396404622$--></slot></template></wc-fetch><!--?lit$396404622$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$396404622$--></div></div><div class="mlt-body"><!--?lit$396404622$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/review-article" target="_self"><!--?lit$396404622$-->Review Article</a> <span class="mlt-article-site-label"><!--?lit$396404622$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$396404622$-->Jul 25, 2024</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMra2308181?query=recirc_Semantic" target="_self">HIV-Associated Tuberculosis</a></div><div class="mlt-article-authors"><!--?lit$396404622$-->G. Meintjes and G. Maartens</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$396404622$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$396404622$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$396404622$-->Apr 27, 2023</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2212616?query=recirc_Semantic" target="_self">Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers</a></div><div class="mlt-article-authors"><!--?lit$396404622$-->L.F. Pittet and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/correspondence" target="_self"><!--?lit$396404622$-->Correspondence</a> <span class="mlt-article-site-label"><!--?lit$396404622$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$396404622$-->Oct 31, 2024</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMc2411285?query=recirc_Semantic" target="_self">HIV-Associated Tuberculosis</a></div><div class="mlt-article-authors"><!--?lit$396404622$--></div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$396404622$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$396404622$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$396404622$-->Jun 18, 2020</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa1910708?query=recirc_Semantic" target="_self">Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults</a></div><div class="mlt-article-authors"><!--?lit$396404622$-->F.-X. Blanc and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$396404622$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$396404622$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$396404622$-->Dec 19, 2024</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2314325?query=recirc_Semantic" target="_self">Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam</a></div><div class="mlt-article-authors"><!--?lit$396404622$-->G.J. Fox and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2412381?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2412381" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2412381.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2412381"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"></template><template id="fv_panel_template" data-sharesocial="Share"></template>
<template id="fv_directory_template" data-overlay="View figure"></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"></template><template id="toCitationAccordionItem"></template><template id="citations_truncate_template"></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"></template><template id="collapsible_authors_template"></template>
<template id="collapsible_tables_collapse_template"></template>
<template id="collapsible_tables_expand_template"></template><template id="authorsAffiliationsLink"></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">BCG Revaccination for the Prevention of <i>Mycobacterium tuberculosis</i> Infection</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="https://www.nejm.org/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="https://www.nejm.org/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="https://www.nejm.org/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="https://www.nejm.org/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="https://www.nejm.org/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2409029" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2415948" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-f0" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f0.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f0.jpg" height="3416" width="2640" aria-labelledby="f0" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title"></div><div class="fv__item__description"><figcaption>Download a PDF of the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#ap0">Research Summary</a>.</figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f1.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f1.jpg" height="3438" width="2253" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Trial Design and Screening, Randomization, Follow-up, and Analyses.</div><div class="notes"><div role="doc-footnote">Panel A shows the trial design. Participants were randomly assigned to the bacille Calmette–Guérin (BCG)–vaccine group or the placebo group, and QuantiFERON-TB (QFT) tests were performed according to trial schedule. Participants who had a QuantiFERON-TB (QFT) test conversion (negative to positive) at day 71 (or if the visit was missed or not feasible to conduct, at the next feasible visit) were excluded from the primary modified intention-to-treat efficacy analysis but were followed for safety and efficacy to the end of the trial. Each participant was followed for safety for a minimum of 6 months after vaccination. Panel B shows the screening, randomization, follow-up, and analysis. Among 3653 persons who had undergone screening, 1817 were excluded from enrollment. The most common ineligibility criteria were a positive QFT test, altered laboratory values, and an abnormal urinalysis result. Protocol deviations leading to exclusion from the modified intention-to-treat population included nonadherence to the investigational product (3 participants in the BCG-vaccine group) and not meeting all eligibility criteria (1 participant in the BCG-vaccine group and 3 in the placebo group). A total of 1836 underwent randomization in a 1:1 ratio to receive BCG revaccination (919 participants) or placebo (917 participants).</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f2.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f2.jpg" height="1901" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Vaccine Efficacy in the Modified Intention-to-Treat Population.</div><div class="notes"><div role="doc-footnote">Panel A shows the cumulative event curves for a sustained QFT test conversion (primary efficacy end point) according to trial visit. Panel B shows the cumulative event curves for a sustained QFT test conversion according to calendar month. Panel C shows the cumulative event curves for an initial QFT test conversion according to trial visit. Panel D shows the proportion of participants with an initial QFT test conversion based on a range of increasingly stringent QFT test conversion thresholds higher than 0.35 IU per milliliter. 𝙸 bars represent 95% confidence intervals.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2412381_f3.jpg"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381_f3.jpg" height="1494" width="2231" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Immunogenicity of BCG Revaccination.</div><div class="notes"><div role="doc-footnote">Shown are the frequencies of antigen-specific CD4 T cells expressing any combination of interferon-<i>γ</i>, tumor necrosis factor, interleukin-2, interleukin-17, or interleukin-22 after stimulation with BCG vaccine, as measured with the use of whole-blood intracellular cytokine staining assay in participants who received BCG revaccination (orange) or placebo (blue). Panel A shows longitudinal responses (plotted on a logarithmic scale) during the first 168 days after vaccination. 𝙸 bars indicated 95% confidence intervals. Panel B shows the area under the curve (plotted on a logarithmic scale) for BCG-specific CD4 T-cell frequencies per participant during the first 168 days after vaccination. Each circle represents an individual participant. The horizontal line within each box indicates the median, the box indicates the interquartile range (quartile 1 to quartile 3), and the whiskers indicate the minimum and maximum values.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Sustained and Initial QFT Test Conversions.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-t2" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 2</div><div class="fv__item__description"><figcaption><div class="caption">Incidence of Adverse Events and Medication Use.<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#fv-t2fn1" role="doc-noteref">*</a></div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="https://www.nejm.org/toc/nejm/392/18" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 392 No. 18</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="https://www.nejm.org/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">May 08, 2025</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#tooltip-video"></use></svg></span></span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2501440" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">L.J. Laffin and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="https://www.nejm.org/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">May 08, 2025</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2408771" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">J. Svoboda and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="https://www.nejm.org/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">May 08, 2025</span></li><li class="issue-item_meta-item"><span class="issue-item_cme">CME</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#tooltip-video"></use></svg></span></span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2415948" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">Y.C. Kudva and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="https://www.nejm.org/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2412381%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2412381&amp;pubId=41391865&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="https://www.nejm.org/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2412381%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2412381&amp;pubId=41391865&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/footer-devices-2x.webp" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="https://www.nejm.org/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejm.org/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright © 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link">Massachusetts Medical Society</a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="0,1,2" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id023773754458165286" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-92351c23cf55fb00d677562c66b56316.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/mmsWidgets.css"><script nonce="" type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/mmsWidgets.js"></script><script nonce="" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><script>_satellite["_runScript1"](function(event, target, Promise) {
window.targetGlobalSettings = {  
   telemetryEnabled: false // Disable Target Telemetry  
};
});</script><script>
/**
 * Adobe Target - Init
 * Action: Add Parameters and Helpers
 * v1.0.2
 * 
 * Changes:
 * - Removed jQuery wait provider
 */

_satellite.getVar("mmsTarget.helper");
//_satellite.getVar("mmsTarget.modal");
// Insert Target Modal CSS 
//mmsTarget.modal.insertCSS();


/*
  MTECH-660 - Update Adobe Target Page Parameter Function 
  https://jira.mms.org/browse/MTECH-660
*/
function targetPageParamsAll(mmsd) {
  parentNode = "";
  strDatalayername = "";
  var profileData = {};
  var configParamsAppendStr = "profile";
  // The configuration below maps data layer nodes to persistent profile parameters
  // All other data layer nodes will be passed on mbox parameters
  // Each data layer node requires its own entry
  // e.g : ["mmsData.user.loginStatus","mmsData.page.url","mmsData.page.name"];
  var configNode = [
    "mmsData.user.audienceSegment",
    "mmsData.user.country",
    "mmsData.user.customerType",
    "mmsData.user.institutionID",
    "mmsData.user.limitedAccess",
    "mmsData.user.loginStatus",
    "mmsData.user.meterCountRemaining",
    "mmsData.user.priorRegStatus",
    "mmsData.user.profession",
    "mmsData.user.specialty",
    "mmsData.user.specialtyCode",
    "mmsData.user.specialtyGroup",
    "mmsData.user.specialtyGroupCode",
    "mmsData.user.status",
    "mmsData.user.subType",
    "mmsData.user.subscriptionExpiryDate",
    "mmsData.user.totalMeterCount",
    "mmsData.user.userID",
    "mmsData.user.workplace",
    "mmsDataAdd.user.accessInstitutionID"
  ];

  var extend = function() {
    for (var i = 1; i < arguments.length; i++)
      for (var key in arguments[i])
        if (arguments[i].hasOwnProperty(key)) arguments[0][key] = arguments[i][key];
    return arguments[0];
  };

  function isEmpty(obj) {
    for (var prop in obj) {
      if (obj.hasOwnProperty(prop)) return false;
    }
    return JSON.stringify(obj) === JSON.stringify({});
  }

  /* Not used
  function isProfileVariable(path) {
    var allowed = false;
    for (var i = 0; i < profiles.length; i++) {
      if (profiles[i] == path) {
        allowed = true;
      }
    }
    return allowed;
  }
  */
  var parseOnlyValues = function(first, datalayername, k) {
    var newData = {};
    if (first && first.length) {
      newData[k] = first; //array
    } else if (typeof first === 'object') {
      Object.keys(first).forEach(function(key) {
        if (first[key] && typeof first[key] === "object") {
          parentNode = key;
          strDatalayername = datalayername;
          var obj = parseOnlyValues(first[key], datalayername, key);
          if (!isEmpty(obj)) {
            profileData[configParamsAppendStr + "." + datalayername + "." + key] = obj;
            newData[datalayername + "." + key] = obj;
          }
        } else if (typeof first[key] !== "object" && (!!first[key] || typeof first[key] === "boolean")) {
          if (configNode.indexOf(strDatalayername + "." + parentNode + "." + key) >= 0) {
            newData["child" + configParamsAppendStr + "." + key] = first[key];
          } else {
            newData[key] = first[key];
          }
        }
      });
    }
    return newData;
  }
  //Remove the element from Json based on the given key  
  var format = function(json_string, key_to_skip) {
    return JSON.parse(json_string, function(key, value) {
      if (key !== key_to_skip) {
        return value;
      }
    });
  }
  // Parse and Clean the data present in the default json node.
  var persistOnlyValuesCleanDefaultNode = function(first, datalayername, k) {
    var newData = {};
    if (typeof first === 'object') {
      Object.keys(first).forEach(function(key) {
        var obj = persistOnlyValuesCleanDefaultNode(first[key], datalayername, key);
        if (key.indexOf(configParamsAppendStr) < 0) {
          for (var node in configNode) {
            var fields = configNode[node].split('.');
            var splitDatalayername = fields[0];
            var splitParentNode = fields[1];
            var splitChildNode = fields[2];
            first[key] = format(JSON.stringify(first[key]), "child" + configParamsAppendStr + "." + splitChildNode);
          }
          newData[key] = first[key];
        }
      });
    }
    return newData;
  }
  // Parse and Clean the data present in the profile json node.	
  var persistOnlyValuesCleanProfileNode = function(first, datalayername, k) {
    var newData = {};
    if (typeof first === 'object') {
      Object.keys(first).forEach(function(key) {
        var obj = persistOnlyValuesCleanProfileNode(first[key], datalayername, key);
        if (key.indexOf(configParamsAppendStr) >= 0) {
          validKeys = [];
          userInput = first[key];
          for (node in configNode) {
            var fields = configNode[node].split('.');
            var splitDatalayername = fields[0];
            var splitParentNode = fields[1];
            var splitChildNode = "child" + configParamsAppendStr + "." + fields[2];
            validKeys.push(splitChildNode);
          }

          //Object.keys(userInput).forEach((key) => validKeys.includes(key) || delete userInput[key]);

          //IE Bug Fix
          if(typeof userInput !== 'object'){
            var temp = {};
            temp[key] = userInput;
            userInput = temp;
          }
          Object.keys(userInput).forEach(function(key) {
            var includesKey =false;
            for(var i=0; i<validKeys.length; i++){ if(validKeys[i] == key) includesKey = true }
            if(includesKey)
              return key;
            else 
              delete userInput[key];
          });

          newData[key] = userInput;
        }
      });
    }
    return newData;
  }
  //Persist the data based on the given config
  var persistOnlyValues = function(first, datalayername, k) {
    mms1 = persistOnlyValuesCleanDefaultNode(first, datalayername, k);
    mms2 = persistOnlyValuesCleanProfileNode(profileData, datalayername, k);
    var str = JSON.stringify(mms2);
    str = str.replace(/childprofile./g, "");
    mms2 = JSON.parse(str);
    var mms3 = extend({}, mms1, mms2);
    return mms3;
  }
  //Parse and Persist the "mmsd" data.
  var mmsd = typeof window.mmsData !== "undefined" ? mmsData : {};
  var mms = parseOnlyValues(mmsd, "mmsData");
  if (configNode.length > 0) {
    mms = persistOnlyValues(mms, "mmsData");
  }
  //Parse and Persist the "mmsdcdf" data.
  var mmsdcdf = typeof window.mmsDataCDF !== "undefined" ? mmsDataCDF : {};
  var cdf = parseOnlyValues(mmsdcdf, "mmsDataCDF");
  if (configNode.length > 0) {
    cdf = persistOnlyValues(cdf, "mmsDataCDF");
  }

  //Add AAM Zamboni segment data (MTECH-7928/MTECH-7861)
  var aamSegQual = _satellite.getVar("aam_sp_bt-segqual_Cookie");
  var aamZamboni = _satellite.getVar("aam_sp_bt-zam_Cookie");
  if(aamSegQual || aamZamboni){
    var aamData = {}
    if(aamSegQual){
        aamData.qualifyingSegment = aamSegQual.substring(0,254);
    }
    if(aamZamboni){
        aamData.zamboniTargetingSegment = aamZamboni.substring(0,254);
    }
    mms['profile.mmsData.aam'] = aamData;
  }
  
  return extend({}, mms, cdf);
}

// MutationObserver to detect DOM readiness for Regional Mboxes
(function(win) {
   'use strict';

   var listeners = [],
      doc = win.document,
      MutationObserver = win.MutationObserver || win.WebKitMutationObserver,
      observer;

   function ready(selector, fn) {
      // Store the selector and callback to be monitored
      listeners.push({
         selector: selector,
         fn: fn
      });
      if (!observer) {
         // Watch for changes in the document
         observer = new MutationObserver(check);
         observer.observe(doc.documentElement, {
            childList: true,
            subtree: true
         });
      }
      // Check if the element is currently in the DOM
      check();
   }

   function check() {
      // Check the DOM for elements matching a stored selector
      for (var i = 0, len = listeners.length, listener, elements; i < len; i++) {
         listener = listeners[i];
         // Query for elements matching the specified selector
         elements = doc.querySelectorAll(listener.selector);
         for (var j = 0, jLen = elements.length, element; j < jLen; j++) {
            // Override to 0 for first match only
            element = elements[0];
            // Make sure the callback isn't invoked with the 
            // same element more than once
            if (!element.ready) {
               element.ready = true;
               // Invoke the callback with the element
               listener.fn.call(element, element);
            }
         }
      }
   }

   // Expose ready
   win.tgtReady = ready;

})(this);
</script><script>_satellite["_runScript2"](function(event, target, Promise) {
_satellite.runOnDomReady = function(inputFunction){
    if (document.readyState === "loading") {
        // Loading hasn't finished yet
        document.addEventListener("DOMContentLoaded", inputFunction);
    } else {
        // `DOMContentLoaded` has already fired
        inputFunction();
    }
}


/* LIBRARY */
_satellite.modals = {
    addToQueue: function(modal){},
    isAllowedPageURL: function(){},
    isAllowedCookie: function(){},
    checkValidModalObject: function(modal){},
    addEventListeners: function(){},
    displayModal: function(){},
    loadHelpers: function(){},
    excludedPagePath: ["/continuing-medical-education","/exam/10.1056/NEJMcme","/doi/full","/do/","/author-center","/media","/cme","/sign-in"],
    modalToDisplay: null,
    listenersAdded: false,
    modalHasBeenDisplayed: false
};


/****** CORE Functionality ******/

/**** Queue ****/
_satellite.modals.addToQueue = function(modal){

    //Check for non-Target modal
    if(modal.source !== "Target"){
        //Currently all non-Target modals take priority
        modal.priority = 100;
        this.modalToDisplay = modal;
        this.log("Non-Target modal will take priority. "+ (modal.name || "Non-Target ") + " modal will be shown.");
        return;
    }

    //Check object is correctly formatted 
    if(this.checkValidModalObject(modal) === false){
        this.log("Modal object is malformed. "+modal.name + " modal will not be shown.");
        if(modal.suppressCallback) { modal.suppressCallback();}
        return false;
    }

    //Check page exceptions
    if(this.isAllowedPageURL() === false){
        this.log("Modals are not allowed on this page. "+modal.name + " modal will not be shown.");
        if(modal.suppressCallback) { modal.suppressCallback();}
        return false;
    }

    //Check cookie status (if modal has already been shown)
    if(this.isAllowedCookie(modal) === false){
        this.log("Modal has already been shown to the user, cookie check failed. "+modal.name + " modal will not be shown.");
        if(modal.suppressCallback) { modal.suppressCallback();}
        return false;
    }

    //Check priority
    var isHighestPriority = true;
    if(this.modalToDisplay){
        //Check if new modal is higher priority
        if(modal.priority < this.modalToDisplay.priority){
            this.log(modal.name + " is lower priority and won't be shown. "+this.modalToDisplay.name + " modal will be shown.");
            isHighestPriority = false;
            if(modal.suppressCallback) { modal.suppressCallback();}
        }
        if(modal.priority === this.modalToDisplay.priority){
            this.log(modal.name + " is same priority level and won't be shown. "+this.modalToDisplay.name + " modal will be shown.");
            isHighestPriority = false;
            if(modal.suppressCallback) { modal.suppressCallback();}
        }
        if(modal.priority > this.modalToDisplay.priority){
            this.log(modal.name + " is higher priority level and will be shown. "+this.modalToDisplay.name + " modal will not be shown.");
            isHighestPriority = true;
            if(this.modalToDisplay.suppressCallback) { this.modalToDisplay.suppressCallback();}
        }
    }else{
        this.log(modal.name + " has been added to the queue.");
    }

    //Modal will likely be shown to user
    if(isHighestPriority){
        this.modalToDisplay = modal;
    }
};

/**** Display ****/
_satellite.modals.displayModal = function(){
    if(_satellite.modals.modalHasBeenDisplayed) return false;

    var modal = _satellite.modals.modalToDisplay;
    _satellite.modals.log(modal.name + " displayed");

    //Check if any other modals are already being displayed
    if(_satellite.getVar("layersVisible") === true){
        _satellite.modals.log("Another modal is already being displayed. " + modal.name + " is NOT allowed to be displayed");
        return false;
    }

    //Set modal cookie & modal display flag
    var expiration = modal.cookieExpirationDays || null;
    _satellite.cookie.set(modal.id, "true", {expires: expiration});
    _satellite.modals.modalHasBeenDisplayed = true;

    //Check if library should display the modal, or simply trigger the callback?
    if(modal.noDisplayJustCallback === true){
        if(modal.triggerCallback) modal.triggerCallback();
        return;
    }

    //Prep analytics
    var modalEventDetails = {
        'locationName': modal.name
        //'promo': 'PROMO_CODE'
    }
    if(modal.promoCode) modalEventDetails.promo = modal.promoCode;

    //Display
    mmsTarget.modal.css();
    mmsTarget.modal.init(modal.id, modalEventDetails);
    

    //Update profile
    adobe.target.getOffer({
        "mbox": "nejm-modal",
        "params": {},
        "success": function (offer) {},
        "error": function (status, error) {
            console.log('[TARGET] Error', status, error);
        }
    });

    //Callback
    if(modal.triggerCallback) modal.triggerCallback();

    //Update cookie on CTA click
    if(modal.hideAfterCtaClick !== false){
        setTimeout(function(){
            var ctaElement = document.querySelector("a.tt-link-cta");
            if(ctaElement){
                ctaElement.addEventListener("click", function(){
                    _satellite.cookie.set(_satellite.modals.modalToDisplay.id, "true", {expires: 600});
                });
            }
        },700); //wait for the HTML to render
    }
}

/**** Trigger ****/
_satellite.modals.addEventListeners = function(){
    var modals = _satellite.modals;
    
    //Load helper scripts
    modals.loadHelpers();

    //This should be run on DOM ready
    if(!modals.modalToDisplay) return; //ensure a modal is in queue
    if(modals.listenersAdded) return; //only execute once
    if(modals.modalToDisplay.source !== "Target"){
        modals.log("Non-Target modal is highest priority. Do not display any modals from Target");
        return;
    }
    var delay = (modals.modalToDisplay.triggerDelaySeconds || 0.1) * 1000;
    if(modals.modalToDisplay.triggerType == "page load"){
        setTimeout(_satellite.modals.displayModal, delay);
    }
    if(modals.modalToDisplay.triggerType == "exit"){
        //Exit intent handler
        jQuery(document).on("mouseout", evt => {
            if (evt.toElement === null && evt.relatedTarget === null) {
                //Display
                _satellite.modals.displayModal();
            }
        });
    }
    modals.listenersAdded = true;
}

/**** HELPERS ****/
_satellite.modals.loadHelpers = function(){
    if(window.mmsTarget && mmsTarget.modal && mmsTarget.modal.css){
        //helpers have already been loaded
        return;
    }
    _satellite.getVar("mmsTarget.modal");
    
    // let scriptEle = document.createElement("script");
    // scriptEle.setAttribute("src", "https://at.nejm.org/help/modal/source/assets/mmsTarget.modal.demo.js");
    // scriptEle.addEventListener("load", () => {
    //     this.log("Script Loaded | mmsTarget.modal.demo.js")
    // });
    // document.body.appendChild(scriptEle);
}

_satellite.modals.log = function(text){
    _satellite.logger.info("Modal Framework| " + text)
}

_satellite.modals.isAllowedCookie = function(modal){
    if(_satellite.cookie.get(modal.id)) 
        return false;
    return true;
}

_satellite.modals.isAllowedPageURL = function(){
    var allow = true;
    var path = location.pathname.toLocaleLowerCase();
    this.excludedPagePath.forEach(function(current){
        current = current.toLocaleLowerCase();
        if(path.indexOf(current) > -1){
            allow = false;
        }
    })
    return allow;
}

_satellite.modals.checkValidModalObject = function(modal){
    if(modal.source == "Target"){
        if(!modal.id){this.log("Modal Object Check Failed | modal.id is missing"); return false;}
        if(!modal.name){this.log("Modal Object Check Failed | modal.name is missing"); return false;}
        if(!modal.priority){this.log("Modal Object Check Failed | modal.priority is missing"); return false;}
        if(!modal.triggerType){this.log("Modal Object Check Failed | modal.triggerType is missing"); return false;}
        if(typeof(modal.cookieExpirationDays) !== "number"){this.log("Modal Object Check Failed | modal.cookieExpirationDays is missing"); return false;}
        if(modal.triggerType != "page load" && modal.triggerType != "exit"){
            this.log("Modal Object Check Failed | modal.triggerType is not an accepted value"); return false;
        }
    }
    return true;
}

//Give Target time to execute and add all modals to queue before evaluating
setTimeout(function(){
  _satellite.runOnDomReady(_satellite.modals.addEventListeners);
}, 1000);
});</script><script>_satellite["_runScript3"](function(event, target, Promise) {
document.addEventListener(adobe.target.event.REQUEST_FAILED, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.REQUEST_SUCCEEDED, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.CONTENT_RENDERING_FAILED, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.CONTENT_RENDERING_SUCCEEDED, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.LIBRARY_LOADED, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.REQUEST_START, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.CONTENT_RENDERING_START, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.CONTENT_RENDERING_NO_OFFERS, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});

document.addEventListener(adobe.target.event.CONTENT_RENDERING_REDIRECT, function(event) { 
  _satellite.logger.info('TARGET: ', event); 
});
});</script><script>_satellite["_runScript4"](function(event, target, Promise) {
var params = {},
    type = _satellite.getVar('objectType')
    articleType = _satellite.getVar("articleType")

//Don't track on proxy domains
if(location.host == "www.nejm.org"){
  if (type === "Quick Take" && !articleType){
      var topics =  _satellite.getVar('objectTopics').split('|')
      topics = topics.map(function(val){
          return val.toLowerCase()
      })
      params["entity.type"] = _satellite.getVar("objectType")
      params["entity.pageUrl"] = window.location.pathname
      params["entity.name"] = _satellite.getVar("objectTitle")
      params["entity.id"] = _satellite.getVar("objectDoi").replace("/", "-")
      params["entity.doi"] = _satellite.getVar("objectDoi")
      params["entity.isFree"] = _satellite.getVar("objectIsFree")
      params["entity.issueDate"] = new Date(_satellite.getVar("objectIssueDate")).toISOString().slice(0,10).replace(/-/g,"")
      params["entity.topics"] = JSON.stringify(topics)
      params["entity.thumbnailUrl"]= _satellite.getVar("metaArticleImage")
  } else {
      params["entity.id"] = _satellite.getVar("articleDoiCleaned")
      params["entity.age"] = _satellite.getVar("articleAge")
      params["entity.doi"] = _satellite.getVar("articleDOI")
      params["entity.name"] = _satellite.getVar("articleTitle")
      params["entity.type"]= _satellite.getVar("articleType")
      params["entity.brand"]= _satellite.getVar("articleBrand")
      params["entity.isFree"]= _satellite.getVar("articleIsFree")
      params["entity.topics"]= _satellite.getVar("articleCategoryTopics")
      params["entity.authors"]= _satellite.getVar("metaArticleAuthors")
      params["entity.pageUrl"]= _satellite.getVar("articleUrlConstructed")
      params["entity.inventory"]= _satellite.getVar("articleInventoryPlaceholder")
      params["entity.issueDate"]= _satellite.getVar("articleIssueDateCleaned")
      params["entity.subtopics"]= _satellite.getVar("articleSubTopicsCleaned")
      params["entity.categoryId"]= _satellite.getVar("articleTopicsForAffinity")
      params["entity.description"]= _satellite.getVar("metaArticleDescription")
      params["entity.publishDate"]= _satellite.getVar("metaArticleDate")
      params["entity.seriesTitle"]= _satellite.getVar("articleSeriesTitle")
      params["entity.lastViewDate"]= _satellite.getVar("articleViewCurrentDate")
      params["entity.thumbnailUrl"]= _satellite.getVar("metaArticleImage")
      params["entity.isOnlineFirst"]= _satellite.getVar("articleIsOnlineFirst")
      params["entity.parentCategory"]= _satellite.getVar("articleParentCategory")
      params["entity.authorsDisplayLong"]= _satellite.getVar("metaArticleAuthorsDisplay")
      params["entity.publishDateDisplay"]= _satellite.getVar("metaArticleDateDisplay")
      params["entity.authorsDisplayShort"]= _satellite.getVar("metaArticleAuthorsDisplayShort")
  }
}
params["at_property"] = _satellite.getVar("targetProperty")
params["browserWidth"] = _satellite.getVar("browserWidth")
params["user.categoryId"] = _satellite.getVar("articleTopicsForAffinity")
params["profile.nejm.specialtyTopics"] = _satellite.getVar("userSpecialtyGroupCodeMapping")
params["profile.mmsDataAdd.user.customerType"] = _satellite.getVar("userCustomerType")
params["profile.mmsDataAdd.user.accessInstitutionID"] = _satellite.getVar("userAccessInstitutionID")

params["profile.catalyst.audienceSegment"] = _satellite.getVar("akamaiProfile_catalyst_audienceSegment")
params["profile.catalyst.insightsCouncilMember"] = _satellite.getVar("akamaiProfile_catalyst_insightsCouncilMember")
params["profile.catalyst.qualifiedForCouncil"] = _satellite.getVar("akamaiProfile_catalyst_qualifiedForCouncil")
params["profile.catalyst.subscriptionStatus"] = _satellite.getVar("akamaiProfile_catalyst_subscriptionStatus")

// remove empty values
Object.keys(params).forEach(function(key){
    if (!params[key] || params[key].length === 0){
        delete params[key]
    }
})

targetPageParams = function() { 
    return params;
}
});</script><script>_satellite["_runScript5"](function(event, target, Promise) {
// Uses the tgtReady function from Adobe Target Init rule
// Mboxes Included:
// N-ad-authstring-subscribe
// N-ad-global-top-right
// N-ad-footer-article
// N-ad-footer
// N-ad-siteWide-rightRail-1
// N-ad-right-rail-300x250-1
// N-ad-imageChallenge-rightRail-2
// N-ad-recentArticles
// N-ad-myNEJM-contextual-top
// N-ad-gateway-body-regwall-QT
// N-ad-gateway-stickyBottom-regwall-QT
// N-ad-gateway-body-regwall-ICM
// N-ad-gateway-stickyBottom-regwall-ICM
// N-ad-gateway-body-PPTdownload
// N-ad-gateway-body-audioDownload
// N-ad-gateway-body-article
// ad-layer-promo-1
//abstract page gateway mbox
//N-ad-abs-gateway-top-banner
//N-ad-abs-gateway-body
//N-ad-abs-gateway-fixed-bottom
//N-ad-image-challenge-right-rail-300x250-1
//N-ad-article-right-rail-300x250-1
//N-ad-global-top-right-240x64-1

function mboxReady(mbox, selector) {
  var property = _satellite.getVar("targetProperty");
  var executed = false;
  tgtReady(selector + " a", function(element) {
    if (!executed) {
      var el = document.querySelector(selector);
      console.log("mbox sidebar-content",el);
      el.classList.add("mbox-name-" + mbox);
      el.setAttribute("data-mbox", mbox);
      el.style.opacity = "0";
      var ela = document.querySelector(selector + " a");
      var mboxParam;
      if (ela) {
        var hrefUrl = ela.getAttribute("href");
        if (hrefUrl) {
          var separators = ['\\\?', '&', '\\*', ':'];
          var tokens = hrefUrl.split(new RegExp(separators.join('|'), 'g'));
          var litId, litUrl, litLoc, litPubId, litPlaceholderId, litProductId;
          tokens.forEach(function(result) {
            var params = result.split("=");
            if (params[0] == 'id') {
              litId = params[1];
            } else if (params[0] == 'url') {
              litUrl = params[1];
            } else if (params[0] == 'loc') {
              litLoc = params[1];
            } else if (params[0] == 'pubId') {
              litPubId = params[1];
            } else if (params[0] == 'placeholderId') {
              litPlaceholderId = params[1];
            } else if (params[0] == 'productId') {
              litProductId = params[1]
            }
          });
          mboxParam = {
            "at_property": property,
            "literatumId": litId,
            "literatumUrl": litUrl,
            "literatumLoc": litLoc,
            "literatumPubId": litPubId,
            "literatumPlaceholderId": litPlaceholderId,
            "literatumProductId": litProductId
          }
        }
      }
      adobe.target.getOffer({
        "mbox": mbox,
        "params": mboxParam,
        "success": function(offer) {
          adobe.target.applyOffer({
            "mbox": mbox,
            "selector": selector,
            "offer": offer
          });
          var elem = document.getElementById("at-mbox-style");
          el.style.opacity = "1";
          if (elem) {
            elem.parentNode.removeChild(elem);
          }
        },
        "error": function(status, error) {
          console.log('Error', status, error);
          var elem = document.getElementById("at-mbox-style");
          el.style.opacity = "1";
          if (elem) {
            elem.parentNode.removeChild(elem);
          }
        }
      });
      executed = true;
    }
  });
}

mboxReady('N-ad-authstring-subscribe', '#N-ad-authstring-subscribe');
mboxReady('N-ad-global-top-right', 'div.N-ad-global-top-right');
mboxReady('N-ad-footer-article', '#N-ad-footer-article');
//mboxReady('N-ad-footer', '#N-ad-footer');
mboxReady('N-ad-bottom-FULLx320-1', '#ad-bottom-FULLx320-1');
mboxReady('N-ad-right-rail-300x250-1', '#ad-right-rail-300x250-1');
mboxReady('N-ad-article-right-rail-300x250-1', '#ad-article-right-rail-300x250-1');
mboxReady('N-ad-image-challenge-right-rail-300x250-1', '#ad-N-image-challenge-right-rail-300x250-1');
mboxReady('N-ad-imageChallenge-rightRail-2', '#N-ad-imageChallenge-rightRail-2');
mboxReady('N-ad-recentArticles', '.N-ad-recentArticles');
mboxReady('N-ad-myNEJM-contextual-top', '#N-ad-myNEJM-contextual-top');
mboxReady('N-ad-gateway-body-regwall-ICM', '#N-ad-gateway-body-regwall-ICM');
mboxReady('N-ad-gateway-stickyBottom-regwall-ICM', '#N-ad-gateway-stickyBottom-regwall-ICM');
mboxReady('N-ad-gateway-body-regwall-QT', '#N-ad-gateway-body-regwall-QT');
mboxReady('N-ad-gateway-stickyBottom-regwall-QT', '#N-ad-gateway-stickyBottom-regwall-QT');
mboxReady('N-ad-gateway-body-PPTdownload', '#N-ad-gateway-body-PPTdownload');
mboxReady('N-ad-gateway-body-audioDownload', '#N-ad-gateway-body-audioDownload');
mboxReady('N-ad-gateway-body-article', '#N-ad-gateway-body-article');
mboxReady('ad-layer-promo-1', '.ad-layer-promo-1');
//abstract page gateway mbox
mboxReady('N-ad-abs-gateway-top-banner', '#ad-gateway-top-banner-1--NEJM-NextGen_001');
mboxReady('N-ad-abs-gateway-body', '.o-gateway');
//mboxReady('ad-gateway-top-banner', '#ad-gateway-top-banner-1--NEJM-NextGen_001');
//mboxReady('ad-gateway-body-1', '.o-gateway');
//mboxReady('Ad-meter-bottom-1', '#gateway-fixed-bottom-NEJMSubscribeADec23_001');
mboxReady('N-ad-global-top-right-240x64-1','.ad-global-top-right-240x64-1');
mboxReady('N-ad-abs-gateway-fixed-bottom', '#gateway-fixed-bottom-NEJMSubscribeADec23_001');
mboxReady('ad-gateway-body-1', '#ad-gateway-body-1');


});</script><style type="text/css">
  /**
   * Ads: GPT - CSS
   * Name: mms.ad.css
   * Version: 2.0.2.0
   * 
   * Changes:
   * - Set MedRectangle z-index to ensure Ad stays below when pop up overlaps.
  **/

  /******************************************************
   * NextGen Common
   * v2.0.2.0
   ******************************************************/
   
	.ad {
    text-align: center;
    position: relative;
  }

  .ad.adLabel:before {
    display: block;
    padding: 0 0 4px 0;
    font-family: "OTNEJMScalaSansLF";
    font-size: 0.625rem;
    font-style: normal;
    font-weight: 400;
    letter-spacing: 0.01em;
    line-height: 1rem;
    text-transform: uppercase;
    content: "ADVERTISEMENT";
    text-align: center;
    color: #666666;
  }

  /* topbanner */
  .adLabelVertical {
    margin-top: 12px;
    margin-bottom: 12px;
  }
  
  @media (min-width: 768px) {
    .ad.adLabelVertical:before {
      position: absolute;
      left: -49px;
      top: 35px;
      transform: rotate(-90deg);
    }
  }
  
  /* adEmpty required by Literatum JS */
  .adEmpty {
    display: none;
  }

  .adEmpty + .ng-page_layout-sidebarSpacing {
    display: none;
  }

  /******************************************************
   * NEJM Specific
   ******************************************************/

  /* -------------------------------------------------- */
  /**
   * topbanner
   * 
   * .js-ad-topbanner gets added to <html> after valid creative
   * .js-ad-topbanner-fixed gets added to <html> for sticky behavior
   */

  /* -------------------------------------------------- */
  /* .ad-topbanner-outer */

    .js-ad-topbanner .ad-topbanner-outer {
      box-sizing: content-box;
      height: 94px; /* 32 + 50 + 12 */
    }
  

  @media screen and (min-width: 768px) {
    .js-ad-topbanner .ad-topbanner-outer {
      height: 114px; /* 12 + 90 + 12 */
    }
  }

  /* -------------------------------------------------- */
  /* .ad-topbanner-inner */
  .js-ad-topbanner .ad-topbanner-inner {
    position: relative;
    z-index: auto !important;
  }

  /* -------------------------------------------------- */
  /* sticky: .js-ad-topbanner-fixed */
  .js-ad-topbanner-fixed .ad-topbanner-outer {
    overflow: hidden;
  }

  .js-ad-topbanner-fixed .ad-topbanner-inner {
    position: fixed;
    top: 0;
    left: 0;
    width: 100%;
    border-bottom: 1px solid #e5e5e5;
    background: #fff;
    z-index: 2000 !important;
  }

  /* -------------------------------------------------- 
   * .ad-topbanner 
   * mobile 
   * Pre set height to DTM: less jumping 
   */
  #DTM_Position_Topbanner {
    height: 94px; /* 32 + 50 + 12 */
  }

  .js-ad-topbanner #DTM_Position_Topbanner {
    height: auto;
  }

  .ad-topbanner {
    position: relative;
    width: 320px;
    margin-left: auto;
    margin-right: auto;
    z-index: 50;
  }

  /* tablet-desktop */
  @media screen and (min-width: 768px) {
    /* Pre set height to DTM: less jumping */
    #DTM_Position_Topbanner {
      height: 114px; /* 12 + 90 + 12 */
    }
    .js-ad-topbanner #DTM_Position_Topbanner {
      height: auto;
    }

    .ad-topbanner {
      width: 728px;
    }
  }

  /* iframe bug fixes */
  .js-ad-topbanner .ad-topbanner > iframe {
    float: left;
    height: 0;
  }

  @media screen and (min-width: 768px) {
    .js-ad-topbanner .ad-topbanner > iframe {
      width: 728px;
      height: 90px;
    }
  }


  /* -------------------------------------------------- */
  /**
   * adhesive
   * 
   * .js-ad-adhesive-fixed gets added to <html> for sticky behavior
   */
  .ad-adhesive-wrap {
    display: none;
    opacity: 0;
  }

  .js-ad-adhesive-fixed .ad-adhesive-wrap {
    display: flex;
    flex-flow: column;
    position: fixed;
    left: 0;
    right: 0;
    top: auto;
    bottom: 0;
    opacity: 1;
    z-index: 1900;
    border-top: 1px solid #e2e2e2;
    background-color: #fff;
    transition: opacity .25s linear 1s;
    padding: 14px 0 15px;
  }

  .ad-adhesive {
    display: none;
  }

  .js-ad-adhesive-fixed .ad-adhesive {
    display: block;
    margin: 0 auto;
    position: relative;
  }
  
  @media screen and (min-width: 768px) {
    .ad-adhesive {
      width: 728px;
    }
    .ad-adhesive > iframe {
      width: 728px;
      height: 90px;
    }
  }

  /* Close Button */
  .ad-adhesive-wrap .close-ad-adhesive {
    position: absolute;
    width: 90px;
    height: auto;
    left: 50%;
    top: 48px;
    margin-left: 330px;
    padding: 5px 10px 4px 5px;
    transform: rotate(90deg);
    font-family: ff-scala-sans-web-pro,Trebuchet MS,sans-serif;
    font-size: 11px;
    font-weight: bold;
    line-height: 13px;
    letter-spacing: .06em;
    text-transform: uppercase;
    text-decoration: none;
    text-align: center;
    color: #333;
  }

  .ad-adhesive-wrap .close-ad-adhesive svg {
    position: absolute;
    top: 7px;
    right: 16px;
  }


  /* -------------------------------------------------- */
  /**
   * interstitial
   */
  .ad-interstitial {
    display: none;
  }

  /* -------------------------------------------------- */
  /* Micro IMG */
  /* -------------------------------------------------- */
  
  .ng-image-challenge_ad {
     position: relative;
  }  

  #DTM_Position_MicroIMG_Wrap {
    background-color: #e5e5e5;
    padding: 12px 16px;
    padding: 0.75rem 1rem;
    display: flex;
    align-items: center;
    justify-content: center;
    height: 50px;
    height: 3.125rem; 
  } 

  #DTM_Position_MicroIMG_Label {
    font-family: "OTNEJMScalaSansLF";
    font-size: 11px;
    font-size: 0.6875rem;
    font-style: normal;
    font-weight: 400;
    letter-spacing: 0.04em;
    line-height: 18px;
    line-height: 1.125rem;
    text-transform: uppercase;
    color: #1a1a1a;
    display: inline-block;
    padding: 5px 93px 0 0;
    padding: 0.3125rem 5.8125rem 0 0;
  }

  #DTM_Position_MicroIMG_Wrap {
    display: none;
  }

  @media screen and (min-width: 768px) {
    #DTM_Position_MicroIMG_Wrap {
      display: flex;
    }

    #DTM_Position_MicroIMG_Wrap.ads-hidden {
      display: none;
    }
  }

  /* Set MedRectangle z-index to ensure Ad stays below when pop up overlaps */
  #DTM_Position_MedRectangle {
    z-index: 0;
  }

</style><script>
/**
 * mms.ad.config.js
 * GPT Configuration
 * Website: www.nejm.org
 * v2.2.0.2
 * 
 * Changelog:
 * - Fixed logic to refresh ads on search filters
 * 
 **/
window.mms = window.mms || {};
window.mms.ad = window.mms.ad || {};
window._satellite = window._satellite || {};

!(function (ad) {
  // Configuration Version
  var configVersion = '2.1.0.0';
  
  // Global Vars
  var global = {
    networkCode: 21823288697,
    adUnit1: 'NEJM',
    adCategory: window.mmsData && window.mmsData.ad && window.mmsData.ad.category
  };

  // Logger
  var log = function(msg) {
    var log = (_satellite && _satellite.logger && _satellite.logger.log) || console.log;
    if (log) log('GPT: mms.ad.config: ' + msg);
  };

  // Mapping of slot pos with <div> id names
  var divNames = {
    'interstitial':    'DTM_Position_InterstitialBanner',
    'topbanner':       'DTM_Position_Topbanner',
    'medrectangle':    'DTM_Position_MedRectangle',
    'multipleoptions': 'DTM_Position_MultipleOptions',
    'microimg':        'DTM_Position_MicroIMG',
    'adhesive':        'DTM_Position_Adhesive'
  };

  // All defineSlots
  var defineSlotsAll = {
    'interstitial': function() {
      var pos = 'interstitial';
      googletag.defineOutOfPageSlot(ad.config.slotName, divNames[pos])
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineOutOfPageSlot: ' + pos);
    },
    'topbanner': function() {
      var pos = 'topbanner';
      var mapping = googletag.sizeMapping()
                             .addSize([768, 0], [728, 90])
                             .addSize([0, 0], [320, 50])
                             .build();
      googletag.defineSlot(ad.config.slotName, [728, 90], divNames[pos])
               .defineSizeMapping(mapping)
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineSlot: ' + pos);
    },
    'medrectangle': function() {
      var pos = 'medrectangle';
      var mapping = googletag.sizeMapping()
                             .addSize([1024, 0], [300, 250])
                             .addSize([768, 0], [])
                             .addSize([0, 0], [300, 250])
                             .build();
      googletag.defineSlot(ad.config.slotName, [300, 250], divNames[pos])
               .defineSizeMapping(mapping)
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineSlot: ' + pos);
    },
    'multipleoptions': function() {
      var pos = 'multipleoptions';
      var mapping = googletag.sizeMapping()
                             .addSize([1024, 0], [[300, 250], [300, 600], [160, 600], [120, 600]])
                             .addSize([0, 0], [])
                             .build();
      googletag.defineSlot(ad.config.slotName, [[300, 250], [300, 600], [160, 600], [120, 600]], divNames[pos])
               .defineSizeMapping(mapping)
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineSlot: ' + pos);
    },
    'microimg': function() {
      var pos = 'microimg';
      var mapping = googletag.sizeMapping()
                             .addSize([768, 0], [88, 31])
                             .addSize([0, 0], [])
                             .build();
      googletag.defineSlot(ad.config.slotName, [88, 31], divNames[pos])
               .defineSizeMapping(mapping)
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineSlot: ' + pos);
    },
    'adhesive': function() {
      var pos = 'adhesive';
      var mapping = googletag.sizeMapping()
                             .addSize([768, 0], [728, 90])
                             .addSize([0, 0], [])
                             .build();
      googletag.defineSlot(ad.config.slotName, [728, 90], divNames[pos])
               .defineSizeMapping(mapping)
               .addService(googletag.pubads())
               .setTargeting('pos', pos);
      log('defineSlot: ' + pos);
    }
  };

  // All Possible Positions
  var allPos = {
    'int-top-med-mul-adh': [ 'interstitial', 'topbanner', 'medrectangle', 'multipleoptions', 'adhesive' ],
    'int-top-med-mul':     [ 'interstitial', 'topbanner', 'medrectangle', 'multipleoptions' ],
    'int-top-med-mic':     [ 'interstitial', 'topbanner', 'medrectangle', 'microimg' ],
    'int-top-med':         [ 'interstitial', 'topbanner', 'medrectangle' ],
    'int-top-mul':         [ 'interstitial', 'topbanner', 'multipleoptions' ],
    'int-top':             [ 'interstitial', 'topbanner' ],
    'int-med':             [ 'interstitial', 'medrectangle' ]
  };
  
  // All Pages: Ad Category vs GPT Ad Units and Sizes
  // Ad Category from data layer: mmsData.ad.category
  var pages = {
    'homepage'                              : { adUnit2: 'homepage'                             , pos: allPos['int-top-med-mic'] },
    'issue-current'                         : { adUnit2: 'issues-current'                       , pos: allPos['int-top-med-mul'] },
    'issue-past'                            : { adUnit2: 'issues-past'                          , pos: allPos['int-top-med-mul'] },
    'loi'                                   : { adUnit2: 'issues-past'                          , pos: allPos['int-top-med-mul'] },
    'recently-published'                    : { adUnit2: 'recently-published'                   , pos: allPos['int-top-med-mul'] },
    'specialty-index'                       : { adUnit2: 'specialty-index'                      , pos: allPos['int-top-mul'] },
    'topics-index'                          : { adUnit2: 'topics-index'                         , pos: allPos['int-top-med'] },
    'allergy-immunology'                    : { adUnit2: 'allergy-immunology'                   , pos: allPos['int-top-med'] },
    'cardiology'                            : { adUnit2: 'cardiology'                           , pos: allPos['int-top-med'] },
    'clinical-medicine'                     : { adUnit2: 'clinical-medicine'                    , pos: allPos['int-top-med'] },
    'dermatology'                           : { adUnit2: 'dermatology'                          , pos: allPos['int-top-med'] },
    'emergency-medicine'                    : { adUnit2: 'emergency-medicine'                   , pos: allPos['int-top-med'] },
    'endocrinology'                         : { adUnit2: 'endocrinology'                        , pos: allPos['int-top-med'] },
    'gastroenterology'                      : { adUnit2: 'gastroenterology'                     , pos: allPos['int-top-med'] },
    'genetics'                              : { adUnit2: 'genetics'                             , pos: allPos['int-top-med'] },
    'geriatrics-aging'                      : { adUnit2: 'geriatrics-aging'                     , pos: allPos['int-top-med'] },
    'hematology-oncology'                   : { adUnit2: 'hematology-oncology'                  , pos: allPos['int-top-med'] },
    'infectious-disease'                    : { adUnit2: 'infectious-disease'                   , pos: allPos['int-top-med'] },
    'nephrology'                            : { adUnit2: 'nephrology'                           , pos: allPos['int-top-med'] },
    'neurology-neurosurgery'                : { adUnit2: 'neurology-neurosurgery'               , pos: allPos['int-top-med'] },
    'nutrition-in-medicine'                 : { adUnit2: 'nutrition-in-medicine'                , pos: allPos['int-top-med'] },
    'obstetrics-gynecology'                 : { adUnit2: 'obstetrics-gynecology'                , pos: allPos['int-top-med'] },
    'pediatrics'                            : { adUnit2: 'pediatrics'                           , pos: allPos['int-top-med'] },
    'psychiatry'                            : { adUnit2: 'psychiatry'                           , pos: allPos['int-top-med'] },
    'pulmonary-critical-care'               : { adUnit2: 'pulmonary-critical-care'              , pos: allPos['int-top-med'] },
    'rheumatology'                          : { adUnit2: 'rheumatology'                         , pos: allPos['int-top-med'] },
    'surgery'                               : { adUnit2: 'surgery'                              , pos: allPos['int-top-med'] },
    'health-policy'                         : { adUnit2: 'health-policy'                        , pos: allPos['int-top-med'] },
    'medicine-and-society'                  : { adUnit2: 'medicine'                             , pos: allPos['int-top-med'] },
    'zika-virus'                            : { adUnit2: 'zika-virus'                           , pos: allPos['int-top-med'] },
    'recognizing-historical-injustices'     : { adUnit2: 'recognizing-historical-injustices'    , pos: allPos['int-top-med'] },
    'fundamentals-of-medical-ethics'        : { adUnit2: 'fundamentals-of-medical-ethics'       , pos: allPos['int-top-med'] },
    'global-health'                         : { adUnit2: 'global-health'                        , pos: allPos['int-top-med'] },
    'data-sharing'                          : { adUnit2: 'data-sharing'                         , pos: allPos['int-top-med'] },
    'pain-management'                       : { adUnit2: 'pain-management'                      , pos: allPos['int-top-med'] },
    'clinical-trials-series'                : { adUnit2: 'the-changing-face-of-clinical-trials' , pos: allPos['int-top-med'] },
    'ebola-virus'                           : { adUnit2: 'ebola-virus'                          , pos: allPos['int-top-med'] },
    'frontiers-in-medicine'                 : { adUnit2: 'frontiers-in-medicine'                , pos: allPos['int-top-med'] },
    'case-studies-in-social-medicine'       : { adUnit2: 'case-studies-in-social-medicine'      , pos: allPos['int-top-med'] },
    'epidemics'                             : { adUnit2: 'epidemics'                            , pos: allPos['int-top-med'] },
    'climate-change'                        : { adUnit2: 'climate-crisis'                       , pos: allPos['int-top-med'] },
    'vaping'                                : { adUnit2: 'vaping'                               , pos: allPos['int-top-med'] },
    'coronavirus'                           : { adUnit2: 'coronavirus'                          , pos: allPos['int-top-med'] },
    'race-and-medicine'                     : { adUnit2: 'race-and-medicine'                    , pos: allPos['int-top-med'] },
    'nam-health-progress'                   : { adUnit2: 'progress-in-health'                   , pos: allPos['int-top-med'] },
    'esc2020'                               : { adUnit2: 'european-society-cardiology'          , pos: allPos['int-top-med'] },
    'covid-vaccine'                         : { adUnit2: 'covid-19-vaccine'                     , pos: allPos['int-top-med'] },
    'gray-matters'                          : { adUnit2: 'gray-matters'                         , pos: allPos['int-top-med'] },
    'fundamentals-of-public-health'         : { adUnit2: 'fundamentals-of-public-health'        , pos: allPos['int-top-med'] },
    'intention-to-treat'                    : { adUnit2: 'intention-to-treat'                   , pos: allPos['int-top-med'] },
    'ai-in-medicine'                        : { adUnit2: 'ai-in-medicine'                       , pos: allPos['int-top-med'] },
    'firearm-injury-prevention'             : { adUnit2: 'firearm-injury-prevention'            , pos: allPos['int-top-med'] },
    'outbreaks'                             : { adUnit2: 'outbreaks'                            , pos: allPos['int-top-med'] },
    'nam'                                   : { adUnit2: 'nam'                                  , pos: allPos['int-top-med'] },
    'equity'                                : { adUnit2: 'equity'                               , pos: allPos['int-top-med'] },
    'conference'                            : { adUnit2: 'conference'                           , pos: allPos['int-top'] },
    'browse'                                : { adUnit2: 'browse'                               , pos: allPos['int-top-med-mul'] },
    'multimedia'                            : { adUnit2: 'multimedia'                           , pos: allPos['int-top-med-mul'] },
    'image-challenge'                       : { adUnit2: 'image-challenge'                      , pos: allPos['int-top-med'] },
    'search'                                : { adUnit2: 'search'                               , pos: allPos['int-top-med-mul-adh'] },
    'search-advanced'                       : { adUnit2: 'search-advance'                       , pos: allPos['int-top-med-mul'] },
    'signin'                                : { adUnit2: 'sign-in'                              , pos: allPos['int-top-med'] },
    'gateway'                               : { adUnit2: 'sign-in'                              , pos: allPos['int-top-med'] },
    'signin-athens'                         : { adUnit2: 'signin-open-athens'                   , pos: allPos['int-top-mul'] },
    'article'                               : { adUnit2: 'article'                              , pos: allPos['int-top-med-mul'] },
    'article-index'                         : { adUnit2: 'article-index'                        , pos: allPos['int-top-mul'] },
    'article-abstract'                      : { adUnit2: 'article'                              , pos: allPos['int-top-med'] },
    'archive-articles-1812'                 : { adUnit2: 'archive-articles-1812'                , pos: allPos['int-top-med'] },
    'archive-articles-1945'                 : { adUnit2: 'archive-articles-1945'                , pos: allPos['int-top-med'] },
    'audio'                                 : { adUnit2: 'audio'                                , pos: allPos['int-top'] },
    'videos-in-clinical-medicine'           : { adUnit2: 'videos-in-clinical-medicine'          , pos: allPos['int-top-med'] },
    'images-in-clinical-medicine'           : { adUnit2: 'images-in-clinical-medicine'          , pos: allPos['int-top-med'] },
    'quick-take-video-summary'              : { adUnit2: 'nejm-quick-take-video-summary'        , pos: allPos['int-top-med'] },
    'visual-abstracts'                      : { adUnit2: 'visual-abstracts'                     , pos: allPos['int-top-med'] },
    'about'                                 : { adUnit2: 'about-nejm'                           , pos: allPos['int-top'] },
    'contact-us'                            : { adUnit2: 'general-subpages'                     , pos: allPos['int-top'] },
    'rss'                                   : { adUnit2: 'rss'                                  , pos: allPos['int-top'] }
  };

  // Set Page Breakpoints
  var breakpoints = {
    desktop: 1024,
    tablet: 768,
    mobile: 0
  };

  // Set Page Ad Information
  // Based on adCategory and currentPage
  var adCategory = _satellite.getVar('adCategory');
  var currentPage,
      slotName,
      divIds,
      defineSlots;
  if (adCategory) {
    // Current Page Information
    currentPage = pages[adCategory];
    if (currentPage) {
      slotName = '/' + global.networkCode + '/' + global.adUnit1 + '/' + currentPage.adUnit2;
      // Get Current Page Slots
      divIds = [];
      defineSlots = (function () {
        var pagePositions = [];
        for (var i = 0; i < currentPage.pos.length; i++) {
          pagePositions.push(defineSlotsAll[currentPage.pos[i]]);
          divIds.push(divNames[currentPage.pos[i]]);
        }
        return pagePositions;
      })();
    } else {
      log('INFO: currentPage undefined');
    }
  } else {
    log('INFO: adCategory undefined');
  }

  // Append Out of Page Ad Positions via JavaScript
  var appendDivHtml = function() {
    // On DOM Ready
    $(function() {
      log('Append Div HTML: init');
      var $body = $('body');
      if ($body.length) {
        $body.append('<div id="DTM_Position_Adhesive" class="ad ad-adhesive"></div>');
        log('Append Div HTML: DTM_Position_Adhesive');
        $body.append('<div id="DTM_Position_InterstitialBanner" class="ad ad-interstitial">');
        log('Append Div HTML: DTM_Position_InterstitialBanner');
      } else {
        log('Append Div HTML: ERROR: $body undefined');
      }
    });
  };

  /**
   * Pre-Render HTML Edits
   */
  var preRenderHtml = function (adContainerId) {
    var $containerDiv = $('#' + adContainerId);
    var wrapperID = adContainerId + '_Wrap';
    log('Pre-render HTML: [' + adContainerId + ']');
    switch (adContainerId) {
      case "DTM_Position_Topbanner":
        (function () {
          $('html').addClass('js-ad-topbanner');
          var wrapperHTML = '<div id="' + wrapperID + '" class="ad-topbanner-outer"><div id="' + wrapperID + 'Inner" class="ad-topbanner-inner"></div></div>';
          var $wrapperContainer = $('#' + wrapperID);
          if ($wrapperContainer.length) {
            log('Pre-render: [' + adContainerId + '] Wrap exists');
          } else {
            $containerDiv.wrap(wrapperHTML);
            log('Pre-render: [' + adContainerId + '] Wrap created');
          }
          $containerDiv.addClass('ad-topbanner');
        })();
        break;
      case "DTM_Position_Adhesive":
        (function () {
          $('html').addClass('js-ad-adhesive');
          var wrapperHTML = '<div id="' + wrapperID + '" class="ad-adhesive-wrap"></div>';
          var $wrapperContainer = $('#' + wrapperID);
          if ($wrapperContainer.length) {
            log('Pre-render: [' + adContainerId + '] Wrap exists');
          } else {
            $containerDiv.wrap(wrapperHTML);
            log('Pre-render: [' + adContainerId + '] Wrap created');
          }
        })();
        break;
      case "DTM_Position_MicroIMG":
        (function() {
          var $wrapperContainer = $('#' + wrapperID);
          if ($wrapperContainer.length) {
            log('Pre-render: [' + adContainerId + '] Wrap exists.');
          } else {
            var wrapperHTML = '<div id="' + wrapperID + '"></div>';
            $containerDiv = $containerDiv.wrap(wrapperHTML);
            $containerDiv = $containerDiv
              .before('<span id="DTM_Position_MicroIMG_Label">Sponsored by</span>')
            log('Pre-render: [' + adContainerId + '] Wrap created');
          }
        })();
        break;
      default:
        log('Pre-render HTML: [' + adContainerId + ']: N/A');
    }
  };

  /**
   * Post Render HTML Edits with Creatives
   * @param {string} adContainerId
   */
  var postRenderHtml = function (adContainerId) {
    log('Post-render: [' + adContainerId + ']');
    var $containerDiv = $('#' + adContainerId);
    
    // Add "adLabel" to all ad positions with creative
    $containerDiv.addClass('adLabel');

    switch (adContainerId) {
      case "DTM_Position_Topbanner":
        // Vertical "Advertisement"
        $containerDiv.addClass('adLabelVertical');
        /* Topbanner Sticky Behavior */
        (function() {
          var options = {
              displayCloseButton: false, // close button display
              timeoutSeconds: 6.2,
              timerId: null,
              timeStart: 0,
              timeEnd: 0,
              timeTotal: 0
            },
            $containerDiv = $('#' + adContainerId),
            wrapperID = adContainerId + '_Wrap',
            fn_closeStickyTopbanner,
            fn_fixTopbanner,
            fn_unstick,
            fn_init;
  
          fn_unstick = function() {
            $('html').removeClass('js-ad-topbanner-fixed');
            options.timeEnd = new Date();
            options.timeTotal = options.timeEnd - options.timeStart;
            log('Post-render: [' + adContainerId + '] sticky total time: [' + options.timeTotal + ']');
          };
          fn_closeStickyTopbanner = function() {
            if (options.displayCloseButton) {
              var $closeButton = $('<a href="#" class="close-ad-topbanner" id="closeTopbannerFixed">Close X</a>');
              $containerDiv.append($closeButton);
              $closeButton.click(function(e) {
                e.preventDefault();
                clearTimeout(options.timerId);
                fn_unstick();
              });
            }
          };
          fn_fixTopbanner = function() {
            var $containerWrap = $('#' + wrapperID);
            if ($containerWrap.length) {
              $('html').addClass('js-ad-topbanner-fixed');
              log('Post-render: [' + adContainerId + '] wrapper exists');
            } else {
              log('Post-render: [' + adContainerId + '] ERROR: wrapper not found');
            }
          };
          fn_init = function() {
            log('Post-render: [' + adContainerId + '] init');
            if ($containerDiv.length) {
              log('Post-render: [' + adContainerId + '] sticky: start');
              fn_fixTopbanner();
              options.timeStart = new Date();
              options.timerId = setTimeout(fn_unstick, options.timeoutSeconds * 1000);
              fn_closeStickyTopbanner();
            } else {
              log('Post-render: [' + adContainerId + '] ERROR: containerDiv not found');
            }
          }();
        })();
        break;
      case "DTM_Position_Adhesive":
        // Vertical "Advertisement"
        $containerDiv.addClass('adLabelVertical');
        /* Adhesive Sticky Behavior */
        (function(config) {
          var options = {
                displayCloseButton: true, // Display Close X Button
                timeoutSeconds: 6.3,
                timerId: null,
                timeStart: 0,
                timeEnd: 0,
                timeTotal: 0
              },
              $containerDiv = $('#' + config.id),
              wrapperID = config.id + '_Wrap',
              fn_unstick,
              fn_closeStickyAd,
              fn_stick,
              fn_init;

          fn_unstick = function() {
            $('html').removeClass('js-ad-' + config.class + '-fixed');
            $('html').removeClass('js-ad-' + config.class);
            options.timeEnd = new Date();
            options.timeTotal = options.timeEnd - options.timeStart;
            log('Adhesive: Post-render: [' + config.id + '] sticky total time: [' + options.timeTotal + ']');
          };
          fn_closeStickyAd = function() {
            var $closeButton = $('#' + config.class + 'Close');
            if ($closeButton.length) {
              log('Adhesive: Post-render: [' + config.id + '] close button exists');
              return;
            }
            if (options.displayCloseButton) {
              log('Adhesive: Post-render: [' + config.id + '] display close button: [true]');
              $containerWrap = $('#' + wrapperID);
              $closeButton = $('<a href="#" class="close-ad-' + config.class + '" id="' + config.class + 'Close">Close<svg width="9" height="9" xmlns="http://www.w3.org/2000/svg"><g><line y1="1" x1="1" stroke="#000" stroke-linecap="undefined" stroke-linejoin="undefined" id="svg_1" y2="8" x2="8" fill="none"/><line transform="rotate(90 4.5 4.5)" stroke="#000" stroke-linecap="undefined" stroke-linejoin="undefined" id="svg_4" y2="8" x2="8" y1="1" x1="1" fill="none"/></g></svg></a>');
              $containerWrap.append($closeButton);
              $closeButton.click(function(e) {
                e.preventDefault();
                clearTimeout(options.timerId);
                fn_unstick();
              });
            } else {
              log('Adhesive: Post-render: [' + config.id + '] display close button: [false]');
            }
          };
          fn_stick = function() {
            var $containerWrap = $('#' + wrapperID);
            if ($containerWrap.length) {
              $('html').addClass('js-ad-' + config.class + '-fixed');
              log('Adhesive: Post-render: [' + config.id + '] wrapper exists');
            } else {
              log('Adhesive: Post-render: [' + config.id + '] ERROR: wrapper not found');
            }
          };
          fn_init = function() {
            log('Adhesive: Post-render: [' + config.id + '] init');
            if ($containerDiv.length) {
              log('Adhesive: Post-render: [' + config.id + '] sticky: start');
              fn_stick();
              options.timeStart = new Date();
              options.timerId = setTimeout(fn_unstick, options.timeoutSeconds * 1000);
              fn_closeStickyAd();
            } else {
              log('Adhesive: Post-render: [' + config.id + '] ERROR: containerDiv not found');
            }
          }();
        })({
          id: adContainerId,
          class: 'adhesive'
        });
        break;
      // MicroIMG - On Complete with creative
      case "DTM_Position_MicroIMG":
        // Remove "adLabel" a No need of "Advertisement" label
        $containerDiv.removeClass('adLabel');
        // Updates wrap display in case it was empty previously
        var $wrapperContainer = $('#' + adContainerId + '_Wrap');
        // MicroIMG Wrap: reset inline display so it defaults to flex in CSS
        $wrapperContainer.css('display', '');
        // Remove .ads-hidden on wrapper
        $wrapperContainer.removeClass('ads-hidden');
        break;
      default:
        log('Post-render HTML: [' + adContainerId + ']: N/A');
    }
  };

  /**
   * Post Render HTML Edits with Empty Creatives
   * 
   * Append class "adEmpty" to all DTM_Position_[xxx] containers if no ad is served
   * @param {string} adContainerId 
   */
  var postRenderHtmlEmpty = function(adContainerId) {
    var $wrapperContainer = $('#' + adContainerId + '_Wrap');
    var $containerDiv = $('#' + adContainerId);
    log('Post-render Empty: [' + adContainerId + ']');
    switch (adContainerId) {
      case "DTM_Position_Topbanner":
        $('html').removeClass('js-ad-topbanner');
        $containerDiv.addClass('adEmpty');
        $wrapperContainer.css('display', 'none');
        break;
      case "DTM_Position_MedRectangle":
        $containerDiv.addClass('adEmpty');
        $wrapperContainer.css('display', 'none');
        break;
      case "DTM_Position_MultipleOptions":
        $containerDiv.addClass('adEmpty');
        $wrapperContainer.css('display', 'none');
        break;
      case "DTM_Position_Adhesive":
        $('html').removeClass('js-ad-adhesive');
        $containerDiv.addClass('adEmpty');
        $wrapperContainer.css('display', 'none');
        break;
      case "DTM_Position_MicroIMG":
        $containerDiv.addClass('adEmpty');
        $wrapperContainer.css('display', 'none');
        break;
      default:
        log('Post-render Empty: [' + adContainerId + ']: N/A');
    }
  };

  /**
   * Slot Render Ended Callbacks
   * Call Post Render HTML Functions
   */
  var slotRenderEnded = function() {
    googletag.pubads().addEventListener('slotRenderEnded', function(event) {
      var isEmpty = event.isEmpty;
      var slotElementId = event.slot.getSlotElementId();
      log('[' + slotElementId + '] slot render ended');
      log('[' + slotElementId + '] is empty: [' + isEmpty + ']');
      if (isEmpty) {
        var postRenderEmptyFn = ad.config.postRenderHtmlEmpty;
        if (!!postRenderEmptyFn) {
          log('[' + slotElementId + '] post render Empty fn: init');
          postRenderEmptyFn(slotElementId);
        } else {
          log('[' + slotElementId + '] post render Empty fn: none');
        }
      } else {
        var postRenderFn = ad.config.postRenderHtml;
        if (!!postRenderFn) {
          log('[' + slotElementId + '] post render fn: init');
          postRenderFn(slotElementId);
        } else {
          log('[' + slotElementId + '] post render fn: none');
        }
      }
    });
  };

  /**
   * Set Targeting
   * 1. userID
   * 2. userspec
   * 3. jwuserspec
   * 4. search
   */
  var setTargeting = function() {
    // 1. NEJM userID (window.mmsData.user.userID)
    var userID = _satellite.getVar('userID');
    log('Targeting: userID: [' + userID + ']');
    googletag.pubads().setTargeting('userID', userID);
    
    // 2. NEJM User Specialty (window.mmsData.user.specialtyGroupCode)
    var userSpecialtyGroupCode = _satellite.getVar('userSpecialtyGroupCode');
    log('Targeting: userspec: userSpecialtyGroupCode [' + userSpecialtyGroupCode + ']');
    googletag.pubads().setTargeting('userspec', userSpecialtyGroupCode);

    // 3. JW User Specialty (cookie name: jw_jspc)
    googletag.pubads().setTargeting('jwuserspec', _satellite.getVar('jwUserSpecialtyGroupCodeInCookie'));

    // 4. Search Term (url query name: q)
    /**
     * Sanitize Search Keyword
     * 1. Trim lead/end whitespace
     * 2. Change all whitespace to hyphens "-"
     * 4. Remove special chars: *
     * 3. Cap max char to 40
     */
    var sanitizeSearch = function() {
      var val = _satellite.getVar('adSearch');
      if (typeof val === 'string') {
        val = val.replace(/["'=!+#*~;^()<>[\],&?:@/%{}|\\]/g, '');
        val = val.trim();
        val = val.replace(/\s+/g, '-');
        val = val.substr(0, 40);
      } else {
        val = '';
      }
      log('Targeting: search: [' + val + ']');
      return val;
    }
    googletag.pubads().setTargeting('search', sanitizeSearch());
  };

  /**
   * Ad Refresh Logic
   */
  var refresh  = (function() {
    // Image Challenge Poll - Refresh
    var imageChallenge = function() {
      // Old Adtech namespace used in Atypon's file: hqfj~product-end.js
      window.mmsAdtech = window.mmsAdtech || {};
      window.mmsAdtech.refreshAdsImageChallenge = function() {
        try {
          googletag.pubads().refresh();
        } catch (error) {
          log('ERROR: mmAdtech.refreshAdsImageChallenge(): could not refresh');
          log(error);
        }
      };
    };

    // Search Page - Refresh on Filter Change
    var search = function() {
      if (adCategory === 'search') {
        log('Search: Filtered - Refresh Ads Event');
        $(document).on('ajaxComplete', (_, __, options) => { 
          if (options.url || options.url.includes("mmsSearchResults")) {
            googletag.pubads().refresh();
            log('Search: Filtered - Refreshed Ads');
          }
        });
      }
    };

    return {
      imageChallenge: imageChallenge,
      search: search
    }
  })();
  
 
  
  /**
   * Set jQuery Wait Max Time
   * 
   * Default: 3000 (3 seconds)
   */
  var jQueryMaxWait = 5000;

  /*
   * This is a hook for executing functions post Init (after jQuery is ready)
  */
  function postInitGpt() {
    refresh.imageChallenge();
    refresh.search();
  }

  // Ad Config
  ad.config = {
    version: configVersion,
    global: global,
    adCategory: adCategory,
    currentPage: currentPage,
    slotName: slotName,
    divIds: divIds,
    defineSlots: defineSlots,
    breakpoints: breakpoints,
    viewportChange: true,
    appendDivHtml: appendDivHtml,
    preRenderHtml: preRenderHtml,
    postRenderHtml: postRenderHtml,
    postRenderHtmlEmpty: postRenderHtmlEmpty,
    slotRenderEnded: slotRenderEnded,
    setTargeting: setTargeting,
    refresh: refresh,
    checkjQuery: true,
    jQueryMaxWait: jQueryMaxWait,
    postInitGpt
  };
})(window.mms.ad);
</script><script>
/**
 * mms.ad.js
 * Google Publisher Tag (GPT)
 * v2.2.0.2
 * 
 * Dependent:
 * - mms.ad.config.js
 * 
 * Changelog:
 *  - postInitGpt which triggers search on filters
 */
window.mms = window.mms || {};
window.mms.ad = window.mms.ad || {};
window._satellite = window._satellite || {};

!(function () {
  /**
   * Logger
   */
  var log = function (msg) {
    var log = (_satellite && _satellite.logger && _satellite.logger.log) || console.log;
    if (log) log('GPT: mms.ad: ' + msg);
  };

  /**
   * Load JavaScript Asynchronously
   * Append to <head>
   */
  var _loadScript = function (url, callback) {
    var script = document.createElement('script')
    script.type = 'text/javascript';
    script.onload = function () {
      callback();
    };
    script.src = url;
    document.getElementsByTagName('head')[0].appendChild(script);
  };

  /**
   * Load GPT Asynchronously
   */
  mms.ad.loadGpt = function () {
    _loadScript('https://securepubads.g.doubleclick.net/tag/js/gpt.js', function () {
      log('Library: gpt.js ready!');
    });
    window.googletag = window.googletag || { cmd: [] };
  };

  /**
   * Get unique identifier based on URL
   * Max 40 characters
   */
  function _kvPid () {
    var path = window.location.pathname;
    // Replace all foward slash "/"
    path = path.replace(/\//g, '');
    // Max path string to 40 characters
    path = path.substr(0, 40);
    // Test for Homepage
    if (path === '') {
      path = 'homepage'
    }
    return path;
  }

  /**
   * Set Viewport Breakpoint KV
   * returns {string} desktop, tablet, mobile
   */
  function _kvBreakpoint () {
    var config = mms.ad.config.breakpoints;
    var width = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
    var breakpoint;
    if (width >= config.desktop) {
      breakpoint = 'desktop';
    } else if (width < config.tablet) {
      breakpoint = 'mobile';
    } else {
      breakpoint = 'tablet';
    }
    log('_kvBreakpoint(): viewport width: [' + width + '] breakpoint: [' + breakpoint + ']');
    mms.ad.config.breakpoint = breakpoint;
    return breakpoint;
  }

  /**
   * Set Staging KV
   * returns {string} yes, no
   */
  function _kvStaging () {
    var launchStaging = _satellite && _satellite.environment && (_satellite.environment.stage !== 'production');
    if (launchStaging) {
      return 'yes';
    } else {
      return 'no';
    }
  }

  /**
   * Listen to DOM for DTM_Position_XXX Elements
   * Find element on DOM
   */
  mms.ad.elemReady = (function () {
    var listeners = [],
      doc = window.document,
      MutationObserver = window.MutationObserver || window.WebKitMutationObserver,
      observer;

    // Check Element in DOM
    function check () {
      // Check the DOM for elements matching a stored selector
      for (var i = 0, len = listeners.length, listener, elements; i < len; i++) {
        listener = listeners[i];
        // Query for elements matching the specified selector
        elements = doc.querySelectorAll(listener.selector);
        for (var j = 0, jLen = elements.length, element; j < jLen; j++) {
          element = elements[j];
          // Make sure the callback isn't invoked with the 
          // same element more than once
          if (!element.ready) {
            element.ready = true;
            // Invoke the callback with the element
            listener.fn.call(element, element);
          }
        }
      }
    }

    // Create Observer
    function ready (selector, fn) {
      // Store the selector and callback to be monitored
      listeners.push({
        selector: selector,
        fn: fn
      });
      if (!observer) {
        // Watch for changes in the document
        observer = new MutationObserver(check);
        observer.observe(doc.documentElement, {
          childList: true,
          subtree: true
        });
      }
      // Check if the element is currently in the DOM
      check();
    }

    return ready;
  })();

  /**
   * GPT - Display Ad
   * 
   * Call googletag.display(ID NAME) when the <div> element is found on page
   * or in this case, use Mutation Observers to watch for the element
   */
  mms.ad.display = function (divId) {
    // GPT AdSlot 1 for Ad unit 'OAO_Test_GPT' ### Size: [[728,90]]
    // Adslot's refresh function: googletag.pubads().refresh([gptadslots[0]])
    // Looks for <div> id="DTM_Position_Topbanner"
    log('[' + divId + '] display: init');
    googletag.cmd.push(function () {
      log('[' + divId + '] display: execute');
      googletag.display(divId);
    });
  };

  /**
   * Display all Ads Positions on Page
   */
  mms.ad.displayAll = function () {
    var divIds = mms.ad.config.divIds;
    log('Listen for: [' + divIds.length + '] div elements');
    for (var i = 0; i < divIds.length; i++) {
      log('[' + i + '] [' + divIds[i] + '] element ready: init');
      // Callback Function for Display Ad
      var display = function () {
        var id = this.id;
        if (id) {
          // Pre render HTML edits
          var preRenderFn = mms.ad.config.preRenderHtml;
          if (!!preRenderFn) {
            preRenderFn(id);
          }
          // Display GPT Ad
          mms.ad.display(id);
          log('[' + id + '] displaying');
        } else {
          log('ERROR: display id: [' + id + '] is undefined');
        }
      };
      var selector = '#' + divIds[i];
      mms.ad.elemReady(selector, display);
    }
  };

  /**
   * Refresh Ads on Viewport or Orientation Change
   * 
   * Only if breakpoint has changed from:
   * - desktop, table, mobile
   */
  mms.ad.viewportChange = function () {
    var breakpoint = mms.ad.config.breakpoint;
    var delay = 500;
    var timer;
    var refreshAds = function (event) {
      timer = setTimeout(function () {
        log('refreshAds(): event: ' + event);
        var newBreakpoint = _kvBreakpoint();
        if (breakpoint !== newBreakpoint) {
          log('viewportChange(): Breakpoints changed from: [' + breakpoint + '] to: [' + newBreakpoint + ']');
          log('viewportChange(): Refresh ads!');
          googletag.pubads().refresh();
          breakpoint = newBreakpoint;
        } else {
          log('viewportChange(): No breakpoint change');
        }
      }, delay);
    };
    window.addEventListener('resize', function (event) {
      clearTimeout(timer);
      refreshAds('resize');
    });
    window.addEventListener('orientationchange', function (event) {
      clearTimeout(timer);
      refreshAds('orientationchange');
    });
  };

  /**
   * Initialize googletag
   */
  mms.ad.initGpt = function () {
    googletag.cmd.push(function () {
      log('Inside: googletag.cmd.push');
      // Define slots
      var config = mms.ad.config;
      var defineSlots = config.defineSlots;
      for (var i = 0; i < defineSlots.length; i++) {
        defineSlots[i]();
      }

      // Set Targeting: Key Values
      googletag.pubads().setTargeting('pid', _kvPid());
      googletag.pubads().setTargeting('breakpoint', _kvBreakpoint());

      // Set Targetin: "test"
      // Only if "?test=[value]" query parameter exists in URL
      var test = (_satellite && _satellite.getVar && _satellite.getVar('adTest'));
      log('Targeting: test: [' + test + ']');
      if (test) {
        googletag.pubads().setTargeting('test', test.substr(0, 40));
      }

      // Set Targetin: "staging" environment
      var staging = _kvStaging();
      log('Targeting: staging: [' + staging + ']');
      googletag.pubads().setTargeting('staging', staging);

      // Set Website Targeting
      if (!!config.setTargeting) {
        config.setTargeting();
      }

      googletag.pubads().enableSingleRequest();
      googletag.pubads().collapseEmptyDivs();

      // slotRenderEnded Callbacks
      if (!!config.slotRenderEnded) {
        config.slotRenderEnded();
      }

      // Enable Services
      googletag.enableServices();

      // Watch for <div> IDs
      mms.ad.displayAll();

      // Refresh Ads on Viewport Orientation Change
      if (!!config.viewportChange) {
        mms.ad.viewportChange();
      }
    });
  };

  /**
   * get cookie value by name, returns '' if name does not exist
   * @param {string} name cookie name
   * @returns cookie value or '' if does not exist
   */
  function _readCookieByName (cname) {
    var name = cname + '=';
    var decodedCookie = decodeURIComponent(document.cookie);
    var ca = decodedCookie.split(';');
    for (var i = 0; i < ca.length; i++) {
      var c = ca[i];
      while (c.charAt(0) == ' ') {
        c = c.substring(1);
      }
      if (c.indexOf(name) == 0) {
        return c.substring(name.length, c.length);
      }
    }
    return '';
  }

  function _getParameterByName (name) {
    name = name.replace(/[\[]/, '\\[').replace(/[\]]/, '\\]');
    var regex = new RegExp('[\\?&]' + name + '=([^&#]*)');
    var results = regex.exec(window.location.search);
    return results === null ? '' : decodeURIComponent(results[1].replace(/\+/g, ' '));
  }

  /**
   * Check if page is going to reload due to SSO. Callback will be called with true/false,
   * true: page will reload and ads should not be shown
   * false: page will NOT reload and ads can be served.
   * This function relies on litSSO object to be available on the page. setInterval stops once litSSO is found or DOMContentLoaded
   */
  function _uccPageRefreshCheck (callback) {
    log('DEBUG: _uccPageRefreshCheck start');

    function dependentElementsReady () {
      var litSsoFound = typeof litSSO !== 'undefined' && litSSO !== null;
      var domReady = document.readyState === 'interactive' || document.readyState === 'complete';
      log('DEBUG: Page Refresh: litSsoFound: ' + litSsoFound + '; domReady: ' + domReady);
      return litSsoFound || domReady;
    }

    function checkSsoPageRefresh () {
      try {
        var ssoActiveCookie = _readCookieByName('mms_ucc_ss_active');
        // UCC-4022, in the litSSO object, accessToken and authState may not always be available
        var litAuth = (window.litSSO && window.litSSO.ucid) ? true : false;
        var ssotoken = _getParameterByName('ssotoken');
        log('DEBUG: Page Refresh: mmsSsoActive:' + !!ssoActiveCookie + '; litAuth:' + litAuth + '; ssotoken found: ' + !!ssotoken);

        if (ssoActiveCookie || ssotoken) {
          log('DEBUG: Page Refresh: mms session active or ssotoken is found in URL');
          if (!litAuth && !window.skipSso) {
            // no lit session, and no skipSso flag, page will refresh to log user in
            log('DEBUG: Page Refresh: TRUE! no lit session, and no skipSso flag, page will refresh to log user in');
            return true;
          }
        } else if (litAuth) {
          // no mms session, but lit session is active, page will refresh to log user out
          log('DEBUG: Page Refresh: TRUE! no mms session, but lit session is active, page will refresh to log user out');
          return true;
        }
        log('DEBUG: Page Refresh: FALSE! no SSO page refresh detected');
        return false;
      } catch (err) {
        log(err);
        log('DEBUG: Page Refresh: FALSE! error');
        return false;
      }
    }

    if (dependentElementsReady()) {
      callback(checkSsoPageRefresh());
      return;
    }

    var intervalId = setInterval(function () {
      if (dependentElementsReady()) {
        clearInterval(intervalId);
        log('DEBUG: Page Refresh: interval cleared');
        callback(checkSsoPageRefresh());
      }
    }, 200);
  }

  /**
   * Check if jQuery Exists
   * @param {*} callback 
   */
  mms.ad.waitjQuery = function (callback) {
    log('waitjQuery');
    var maxWait = mms.ad.config.jQueryMaxWait || 3000;
    var counter = maxWait;
    var interval = 50;
    var intervalTimer = setInterval(function () {
      if (counter < 0) {
        clearInterval(intervalTimer);
        log('waitjQuery: Timed Out');
        log('waitjQuery: Wait time: [' + (maxWait - counter) + ']');
      } else if (typeof window.jQuery === 'function') {
        clearInterval(intervalTimer);
        log('waitjQuery: Found');
        log('waitjQuery: Wait time: [' + (maxWait - counter) + ']');
        $ = window.jQuery;
        callback();
      }
      counter = counter - interval;
    }, interval);
  };

  /**
   * Initialize MMS GPT
   */
  mms.ad.init = function () {
    var config = mms.ad.config;
    if (!config) {
      log('ERROR: Missing mms.ad.config');
      return false;
    }
    if (!config.adCategory) {
      log('INFO: NO AD DISPLAY: Missing adCategory');
      return false;
    }
    if (!config.currentPage) {
      log('INFO: NO AD DISPLAY: Missing currentPage');
      return false;
    }

    // Append extra <div> positions
    config.appendDivHtml();

    // Initialize GPT
    mms.ad.loadGpt();
    mms.ad.initGpt();
    if (config.postInitGpt){
      config.postInitGpt();
    }
     
  };

  // Execute Pre-Init Configs
  mms.ad.preInit = function () {
    if (mms.ad.config && mms.ad.config.checkjQuery) {
      log('waitjQuery: Called');
      mms.ad.waitjQuery(mms.ad.init);
    } else {
      log('init: Called');
      mms.ad.init();
    }
  };

  log('environment: ' + _satellite.environment.stage);
  if (_satellite.environment.stage === 'production') {
    // add check on the SSO page refresh
    _uccPageRefreshCheck(function (pageReloadDetected) {
      if (!pageReloadDetected) {
        mms.ad.preInit();
      }
    });
  } else {
    log('Non-production environment: Called');
    mms.ad.preInit();
  }

})();
</script><script>_satellite["_runScript6"](function(event, target, Promise) {

/* 
    Run in activity map - region.
    Executed on every ActivityMap click.
    Populates finding method in sessionStorage if conditions are met.
*/
_satellite.setFindingMethods = function (clickedElement) {
    if(!clickedElement) return
    var region = s.ActivityMap.region(clickedElement);
    if(region == "BODY") region = ""; //ignore ActivityMap default
    function getPageType() {
        //updated logic added to data element
        var pageType = _satellite.getVar("pageType");
        if (pageType) return pageType;
        return "";

    }

    function getFindingType(clickedElement, region) {
        region = region || "";
        //add logic
        if (clickedElement && clickedElement.getAttribute("data-interactiontype") == "search_click_through") return "Search Results";
        if (region.indexOf("recirc_") === 0) return "Recirculation Widget";
        if (region.indexOf("featured_") === 0) return "Curated Widget";
        if (_satellite.getVar("pageType") == "Digital Object Standalone") return "Digital Object Standalone";
        return "";
    }

    var pageType = getPageType();
    var findingType = getFindingType(clickedElement, region);

    if (!pageType && !type && !region) {
        return; //no value to store
    }

    var fullFindingMethod = [];
    fullFindingMethod.push(pageType || "");
    fullFindingMethod.push(findingType || "");
    fullFindingMethod.push(location.pathname.toLocaleLowerCase());
    fullFindingMethod.push(region || "");
    fullFindingMethod = fullFindingMethod.join("|");


    //Store value on browser - picked up by "Article Page" & "Digital Object Standalone Page" rules
    _satellite.logger.info("Finding Method Store: " + fullFindingMethod);
    sessionStorage.setItem("s_afFM", fullFindingMethod); //Article finding method
    sessionStorage.setItem("s_doFM", fullFindingMethod); //DO standalone finding method
}

/* 
    Run in page load rules
    Checks current page doesn't match path (article can't be a finding method to itself)
    Clears session storage
    Sets value in data layer (which is used in doPlugins to track on click events)
    Sets eVar
*/
_satellite.populateFindingMethodDate = function(isDoPage){
    var storageKey = isDoPage ? "s_doFM" : "s_afFM";
    var findingMethod = sessionStorage.getItem(storageKey);
    if(findingMethod){
        var fmPath = findingMethod.split("|")[2];
        if(location.pathname.toLowerCase() != fmPath){ //don't track if on the same page.
            sessionStorage.setItem(storageKey, ""); //clear
            if(isDoPage) {
                mmsData.object.findingMethod = findingMethod; //used for on page click events (eg downloads)   
                s.eVar23 = findingMethod;
            }
            else {
                mmsData.article.findingMethod  = findingMethod;
                s.eVar51 = findingMethod;
            }
        }
    }
}
});</script><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/get.html" style="display: none;"></iframe><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/v1.7-1626" async="async" crossorigin="" importance="high" nonce=""></script>
        


        
        

            <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce=""></script>

        <script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/main.bundle-3c7054a54963eb9e7568.js" nonce=""></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/1123611~product.js" nonce=""></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>




























    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/1123611~article-metrics.js" nonce=""></script>
            
            
            
        
    




<script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/1123611~full-text-analytics.js" nonce=""></script>


    


            <script defer="" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;93cd748b3c4b0f9f&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.4.0-1-g37f21b1&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script>

        
        
    

<div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="https://www.nejm.org/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div><div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com/" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/sm.25.html" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><script>
/**
 * "Sign up for the free [Alerts/TOC] email" Module Fix
 * v1.0.1
 * Temporary fix:
 * - z-index
 * - reponsive box
 */
(function() {
  var css = '<style>'+
  '  /* Fluid width & height */'+
  '  @media only screen and (min-width: 1024px) {'+
  '    .pb-house-message .bads_right-rail-alert {'+
  '      width: auto;'+
  '    }'+
  '  }'+
  ''+
  '  .pb-house-message .bads_right-rail-alert {'+
  '    height: auto;'+
  '  }'+
  ''+
  '  /* Remove z-index */'+
  '  .pb-house-message .bads_recent-publish-alert .bads_abs-img-link,'+
  '  .pb-house-message .bads_recent-publish-alert .bads_abs-img,'+
  '  .pb-house-message .bads_right-rail-alert .bads_btn-arrow,'+
  '  .pb-house-message .bads_right-rail-alert .bads_abs-img-link .bads_abs-img {'+
  '    z-index: auto;'+
  '  }'+
  '</style>';
  $(function() {
    $('body').append(css);
  });
})();
</script><script>_satellite["_runScript7"](function(event, target, Promise) {
// jQuery AJAX with cache enabled
jQuery.cachedScript = function( url, options ) {
  // Allow user to set any option except for dataType, cache, and url
  options = $.extend( options || {}, {
    dataType: "script",
    cache: true,
    url: url
  });
 
  // Use $.ajax() since it is more flexible than $.getScript
  // Return the jqXHR object so we can chain callbacks
  return jQuery.ajax( options );
};
});</script><script src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/init-180323l4eo513mmefx3.js" data-cfasync="false" async=""></script><script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/nejmoa2412381"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="DTM_Position_Adhesive" class="ad ad-adhesive"></div><div id="DTM_Position_InterstitialBanner" class="ad ad-interstitial" style="display: none;" data-google-query-id="COS0usCflY0DFf-kWgUdEVsLlw"><div id="google_ads_iframe_/21823288697/NEJM/article_0__container__" style="border: 0pt none;"></div></div><style>  /* Fluid width & height */  @media only screen and (min-width: 1024px) {    .pb-house-message .bads_right-rail-alert {      width: auto;    }  }  .pb-house-message .bads_right-rail-alert {    height: auto;  }  /* Remove z-index */  .pb-house-message .bads_recent-publish-alert .bads_abs-img-link,  .pb-house-message .bads_recent-publish-alert .bads_abs-img,  .pb-house-message .bads_right-rail-alert .bads_btn-arrow,  .pb-house-message .bads_right-rail-alert .bads_abs-img-link .bads_abs-img {    z-index: auto;  }</style>
<noscript></noscript><script>
(function(){var g=function(e,h,f,g){
  this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};
  this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};
  this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};
  this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}};
  this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};};
  try{(new g(100,"r","QSI_S_ZN_3OWdQdLXu72cWNv","https://zn3owdqdlxu72cwnv-nejm.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_3OWdQdLXu72cWNv")).start()}catch(i){}
})();
  
(function() {
  // Create the div element
  var div = document.createElement('div');
  div.id = 'ZN_3OWdQdLXu72cWNv';
  var divComment = document.createComment('DO NOT REMOVE-CONTENTS PLACED HERE');
  div.appendChild(divComment);
  document.getElementsByTagName('body')[0].appendChild(div);
})();
</script><div id="ZN_3OWdQdLXu72cWNv"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div><script>_satellite["_runScript8"](function(event, target, Promise) {
/*
The iFrame uses 'postMessage' to send information to the parent frame.
The below code listens for those events and send AA tracking.
*/
_satellite.receiveVideoMessage = function(event) {
  if(!window.s)return;
  if(event.data.eventAction){
    s.eVar47 = event.data.title || s.pageName;
    var videoType = "Component Video";
    if(event && event.detail && event.data.universalAnalytics && event.data.universalAnalytics.eventCategory){
      var cat = event.data.universalAnalytics.eventCategory;
      if(cat.indexOf("VCM")>-1 || cat.indexOf("Clinical Medicine")>-1 ){
        videoType = "VCM";
      }
      if(cat.indexOf("Quick")>-1 || cat.indexOf("QT")>-1 ){
        videoType = "Quick Take";
      }
    }

    //If duration in the data so, then check the event object
    if(!_satellite.getVar("objectDurationBucket") && event.data.totalDuration){
      mmsData.object.totalDuration = event.data.totalDuration;
    }
    s.eVar55 = s.prop49 = videoType;
    s.eVar59 = _satellite.getVar("objectAge");
    s.eVar58 = s.prop52  = _satellite.getVar("objectDurationBucket");
    s.eVar60 = s.prop73  = event.data.doi || _satellite.getVar("objectDoi");
    s.eVar49 = (_satellite.getVar("objectTotalDuration") || "").replace(".0","");
    var events = "";
    var linkName = "";
    var action = event.data.eventAction;
    
    if(action == "Play"){
      events = "event120";
      linkName = "Video Play";
    }else if(action == "25% Completed"){
      events = "event58";
      linkName = "Video Milestone - 25%";
    }else if(action == "50% Completed"){
      events = "event59";
      linkName = "Video Milestone - 50%";
    }else if(action == "75% Completed"){
      events = "event60";
      linkName = "Video Milestone - 75%";
    }else if(action == "90% Completed"){
      events = "event178";
      linkName = "Video Milestone - 90%";
    }else if(action == "95% Completed"){
      events = "event179";
      linkName = "Video Milestone - 95%";
    }else if(action == "100% Completed"){
      events = "event61";
      linkName = "Video Complete";
    }
    
    //Exit if no relevent event is set
    if(!events){
      return;
    }
    /* These two list vars have hit experation but we want them associated with this event. */
    s.list1 = _satellite.getVar('articleSpecialties');
    s.list2 = _satellite.getVar('articleTopics');
    
    s.events = s.linkTrackEvents = events;
    s.linkTrackVars = "events,eVar55,eVar58,eVar59,eVar60,eVar47,eVar49,prop49,prop52,prop73,list1,list2";
    s.tl(this,"o",linkName);
  }
}
window.addEventListener("message", _satellite.receiveVideoMessage, false);
});</script><script>_satellite["_runScript9"](function(event, target, Promise) {
if (window.$) {
    if (document.querySelector("#article_introduction > div > div > p:nth-child(2)")) {
        $("#article_introduction > div > div > p:nth-child(2)").after("<div data-mboxid='nejm-article-inline' data-location='mbox' data-location-name='nejm-article-inline'></div>");
        adobe.target.getOffer({
            "mbox": "nejm-article-inline",
            "success": function(offer) {
                adobe.target.applyOffer({
                    "mbox": "nejm-article-inline",
                    "selector": "div[data-mboxid='nejm-article-inline']",
                    "offer": offer
                });
            },
            "error": function(status, error) {
                console.log('Error', status, error);
            }
        });
        _satellite.logger.info("TARGET: Selector for nejm-article-inline mbox found - mbox call fired");
    }
    else {
        _satellite.logger.info("TARGET: Selector for nejm-article-inline mbox missing - mbox call skipped");
    }
}
});</script><iframe name="captureIFrame_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-transactionid="7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" id="captureIFrame_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource(5).html" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" target="captureIFrame_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}" data-gtm-form-interact-id="0"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="✓" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="capture_screen"><input id="capture_signIn_js_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="js_version"><input id="capture_signIn_transactionId_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" type="hidden" class="capture_transactionId_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="capture_transactionId"><input id="capture_signIn_form_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="form"><input id="capture_signIn_flow_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="flow"><input id="capture_signIn_client_id_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="client_id"><input id="capture_signIn_redirect_uri_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="redirect_uri"><input id="capture_signIn_response_type_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="response_type"><input id="capture_signIn_flow_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="flow_version"><input id="capture_signIn_settings_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="settings_version"><input id="capture_signIn_locale_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="locale"><input id="capture_signIn_recaptcha_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_7a7d4ducd0z54dgz68no0s1ppg0rnv48diso44o8" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress capture_validated" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress" data-capturescreenname="signIn" data-gtm-form-interact-field-id="0"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword capture_validated" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword" data-capturescreenname="signIn" data-gtm-form-interact-field-id="1"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div><script src="https://www.nejm.org/doi/full/10.1056/NEJMoa2412381" async=""></script><script type="text/javascript" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/saved_resource(2)"></script><iframe src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/aframe.html" width="0" height="0" style="display: none;"></iframe></body><iframe name="goog_topics_frame" src="./BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection _ New England Journal of Medicine_files/topics_frame.html" style="display: none;"></iframe></html>